0001683168-16-000762.txt : 20161121 0001683168-16-000762.hdr.sgml : 20161121 20161121172510 ACCESSION NUMBER: 0001683168-16-000762 CONFORMED SUBMISSION TYPE: 10-QT PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161121 DATE AS OF CHANGE: 20161121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DTHERA SCIENCES CENTRAL INDEX KEY: 0001586372 STANDARD INDUSTRIAL CLASSIFICATION: CUTLERY, HANDTOOLS & GENERAL HARDWARE [3420] IRS NUMBER: 900925768 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-QT SEC ACT: 1934 Act SEC FILE NUMBER: 333-191175 FILM NUMBER: 162011172 BUSINESS ADDRESS: STREET 1: 9921 CARMEL MOUNTAIN ROAD, SUITE 118 CITY: SAN DIEGO STATE: CA ZIP: 92129 BUSINESS PHONE: (858) 215-6360 MAIL ADDRESS: STREET 1: 9921 CARMEL MOUNTAIN ROAD, SUITE 118 CITY: SAN DIEGO STATE: CA ZIP: 92129 FORMER COMPANY: FORMER CONFORMED NAME: Knowledge Machine International, Inc. DATE OF NAME CHANGE: 20141107 FORMER COMPANY: FORMER CONFORMED NAME: Songbird Development Inc. DATE OF NAME CHANGE: 20130910 10-QT 1 dthera_10q-093016.htm FORM 10-QT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☐

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from September 30, 2016 (Q1) to September 30, 2016 (Q3) (see explanatory note.)

Commission File Number: 333-191175

DTHERA SCIENCES

(Exact name of registrant as specified in its charter)

Nevada	90-0925768
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

7310 Miramar Rd., San Diego, CA 92126	03301
(Address of principal executive offices)	(Zip Code)

(858) 215-6360

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports).

Yes x No o

Indicate by check mark whether the registrant has been subject to such filing requirements for the past 90 days.

Yes o No x

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

	Large accelerated filer	o	Accelerated filer	o
	Non-accelerated filer	o	Smaller reporting company	x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o No x

The number of shares outstanding of the registrant’s common stock on November 21, 2016, was 40,000,000.

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION	3
Item 1. Financial Statements (unaudited)	3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Item 3. Quantitative and Qualitative Disclosures About Market Risk	23
Item 4. Controls and Procedures	23
PART II – OTHER INFORMATION	23
Item 1A. Risk Factors	23
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	23
Item 5. Other Information	24
Item 6. Exhibits	24
SIGNATURES	25

EXPLANATORY NOTE

As reported by Dthera Sciences (formerly Knowledge Machine International, Inc.) (the “Company”) in a Current Report filed with the Commission on September 27, 2016, the Company closed a transaction whereby it acquired 100% of the outstanding stock of EveryStory, Inc., a Delaware corporation (“EveryStory”). The transaction is referred to in this Quarterly Report as the “EveryStory Transaction.”

On November 21, 2016, the Company filed an amendment to the prior current report to provide the financial statements of EveryStory as well as pro forma financial statements, all as required by the Commission’s rules. EveryStory’s year end is December 31, and the financial statements provided included the audited financial statements for the years ended December 31, 2015 and 2014, as well as reviewed interim financial statements through June 30, 2016.

As reported by the Company on a Current Report filed on November 17, 2016, the Company changed its fiscal year end from June 30 to December 31, to better track to the operations and business of the Company’s subsidiary, EveryStory, Inc., the operations of which have become the business and operations of the Company.

The Company will file a Transition Report on Form 10-KT to provide the audited financial statements for the year ended December 31, 2016, following which time, the Company will report on a December 31 year-end basis.

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

DTHERA SCIENCES

FKA Knowledge Machine International, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30,			December 31,
	2016			2015
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash	$	115,531		$	27,238
Prepaid expenses		5,000			21,390
Deposits		1,000			1,000
TOTAL CURRENT ASSETS		121,531			49,628

LONG TERM ASSETS
Property and equipment, net		936			1,648
TOTAL LONG TERM ASSETS		936			1,648

TOTAL ASSETS	$	122,467		$	51,276

LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts payable and accrued liabilities	$	139,960		$	149,965
Accrued interest		–			17,993
Derivative liabilities		191,949			–
Notes payable-related party		–			61,064
Notes payable		20,000			–
Convertible notes payable, net		11,178			189,243
Convertible notes payable-related party, net		–			29,114
TOTAL CURRENT LIABILITIES		363,087			447,379

LONG TERM LIABILITIES
Convertible notes payable, net		–			270,000
Convertible notes payable-related party, net		–			30,000
TOTAL LONG TERM LIABILITIES		–			300,000

TOTAL LIABILITIES		363,087			747,379

STOCKHOLDERS' DEFICIT
Preferred stock 1,000,000 Shares Authorized; $0.001 Par Value; 112,690 and 0 shares issued and outstanding as at September 30, 2016 and December 31, 2015		11			–
Common stock 200,000,000 Shares Authorized; $0.001 Par Value; 40,000,000 and 14,353,091 shares issued and outstanding as of September 30, 2016 and December 31, 2015		40,000			14,311
Additional paid in capital		1,159,377			73,182
Accumulated deficit		(1,440,008	)		(783,596	)
Total Stockholders' Deficit		(240,620	)		(696,103	)
Total Liabilities and Stockholders' Deficit	$	122,467		$	51,276

The accompanying notes are an integral part of these condensed financial statements

DTHERA SCIENCES

FKA Knowledge Machine International, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	For the Three Months Ended September 30,			For the Three Months Ended September 30,			For the Nine Months Ended September 30,			For the Nine Months Ended September 30,
	2016			2015			2016			2015

REVENUES
Sales	$	–		$	–		$	–		$	–
Cost of services		–			–			–			–
GROSS PROFIT		–			–			–			–

OPERATING EXPENSES
Amortization and depreciation		239			–			712			–
General and administrative		136,209			177,010			388,402			259,229
Professional fees		183,312			37,317			212,464			137,934
TOTAL OPERATING EXPENSES		319,760			214,327			601,578			397,163

OPERATING LOSS		(319,760	)		(214,327	)		(601,578	)		(397,163	)

OTHER EXPENSES
Interest expense		(32,962	)		(6,805	)		(68,800	)		(6,953	)
Derivative expense		(30,197	)		–			(30,197	)		–
Gain on derivative liability		68,248			–			68,248			–
Gain on extinguishment of debt		34,875			–			34,875			–
Impairment of intangible assets		–			–			(58,960	)		–
TOTAL OTHER EXPENSES		39,964			(6,805	)		(54,834	)		(6,953	)

NET LOSS	$	(279,796	)	$	(221,132	)	$	(656,412	)	$	(404,116	)

WEIGHTED AVERAGE SHARES OUTSTANDING
Basic and diluted		17,713,943			14,774,889			15,512,115			11,852,384

Loss per share
Basic and diluted	$	(0.02	)	$	(0.01	)	$	(0.04	)	$	(0.03	)

The accompanying notes are an integral part of these condensed financial statements

DTHERA SCIENCES

FKA Knowledge Machine International, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Nine Months Ended September 30,

	2016			2015
	(Unaudited)			(Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (Loss)	$	(656,412	)	$	(404,116	)
Adjustments for non-cash items:
Amortization and depreciation		17,316			–
Impairment of intangible assets		58,960			–
Stock issued for services		16,750			–
Gain on extinguishment of debt		(34,875	)		–
Gain on derivative liability		(68,248	)		–
Initial derivative expense		30,197			–
Options issued for services		105,141			–
Operating expense paid in behalf of the company		20,627			38,859
Changes in operating assets and liabilities:
Prepaid expenses		16,390			(18,992	)
Deposits		–			(1,000	)
Accounts payable and accrued liabilities		166,350			153,524
Accrued interest		52,197			6,953
NET CASH USED IN OPERATING ACTIVITIES		(275,607	)		(224,772	)

CASH FLOWS FROM INVESTING ACTIVITIES
Property and equipment		–			(2,166	)
NET CASH USED IN INVESTING ACTIVITIES		–			(2,166	)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock, net		–			3,962
Proceeds from issuance of notes payable		20,000			–
Proceeds from issuance of notes payable - related party		–			25,000
Proceeds from issuance of convertible notes		330,000			140,000
Proceeds from issuance of notes payable - related party		94,000			–
Proceeds from issuance of convertible notes - related party		–			115,000
Payments of notes payable - related party		(80,100	)		(58,033	)
NET CASH PROVIDED BY FINANCING ACTIVITIES		363,900			225,929

NET CHANGE IN CASH AND CASH EQUIVALENTS		88,293			(1,009	)

CASH AND CASH EQUIVALENTS
Beginning of period		27,238			8,641

End of period	$	115,531		$	7,632

NON-CASH INVESTING AND FINANCING ACTIVITIES
Shares issued for assets	$	58,960		$	–
Common stock issued for interest	$	6,700		$	–
Preferred shares issued for debt	$	112,690		$	–
Share issued in settlement of stock options	$	4,135		$	–
Shares issued in settlement of debt	$	731,391		$	–
Assets & liabilities settled in Share exchange	$	56,355		$	–
Debt discount on convertible debt	$	240,000		$	–

The accompanying notes are an integral part of these condensed financial statements

DTHERA SCIENCES

FKA Knowledge Machine International, Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2016, and December 31, 2015

NOTE 1 – CONDENSED FINANCIAL STATEMENTS

The accompanying financial statements of Dthera Sciences (the “Company”) have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at September 30, 2016, and for all periods presented herein, have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's December 31, 2015 audited financial statements. The results of operations for the periods ended September 30, 2016 and 2015 are not necessarily indicative of the operating results for the full years.

NOTE 2 – GOING CONCERN

The Company's financial statements are prepared using U.S. GAAP applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. As of the date of this Report, the Company had an accumulated deficit of $1,440,008, negative working capital of $240,620, and no revenues to cover its operating costs, which raises substantial doubt about its ability to continue as a going concern. As of the date of this Report, the Company had not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern.

The future of the Company as an operating business will depend on its ability to (1) obtain sufficient capital contributions and/or financing as may be required to sustain its operations and (2) to achieve adequate revenues from its operations. Management's plan to address these issues includes, (a) continued exercise of tight cost controls to conserve cash, (b) obtaining additional financing, (c) placing revenue producing services into place (d) identifying and executing on additional revenue generating opportunities.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Business – Dthera Sciences (formerly Knowledge Machine International, Inc.) is a Nevada corporation, and was incorporated on December 12, 2013.

The Company offers a subscription-based service that captures, shares, and stores photos and audio in cloud. It offers the EveryStory platform, which enables users to preserve and share memories, and will initially target a Quality of Life benefit in certain patient populations, principally patients suffering from Alzheimer’s disease and dementia. On September 21, 2016, the Company acquired a new operating subsidiary, EveryStory, Inc., a Delaware corporation (“EveryStory”). Following the acquisition (referred to herein as the “EveryStory Transaction”), the Company’s business is to develop a Digital Therapeutic technology designed to deliver Reminiscence Therapy to certain patient populations, principally patients suffering from Alzheimer’s disease and dementia with the goal of a Quality of Life benefit and reduction in anxiety in those populations. As of the date of this Report, EveryStory was our only subsidiary. In connection with the EveryStory transaction, the Company dissolved its other former subsidiary entity and terminated its prior business operations.

Acquisition of EveryStory; EveryStory Transaction

On September 21, 2016, the Company entered into an Amended and Restated Acquisition and Share Exchange Agreement (the “A&R Agreement”) with EveryStory, Inc., a Delaware corporation (“EveryStory”), and each of its shareholder (the “Shareholders”), and closed the acquisition (the “Acquisition”) of the ownership of EveryStory (the “Closing”).

The Company acquired all of the outstanding shares of EveryStory, and agreed to issue an aggregate of 77,377,712 shares of the Company’s common stock to the EveryStory holders, with the understanding that an additional 45,247,288 shares were to be reserved for issuance to holders of EveryStory derivative securities which are convertible or exercisable into shares of EveryStory common stock (collectively, the “Exchange Shares”). Additionally, prior to Closing, the parties agreed that certain shares of the Company’s common stock were to be returned to the Company for cancellation, resulting in the current Company’s shareholders owning an aggregate of 40,875,000 shares of the Company’s common stock immediately prior to the Closing.

Pursuant to the A&R Agreement, the 122,625,000 Exchange Shares issued or to be issued to the EveryStory constituted 75% of the total issued and outstanding shares of the Company’s common stock, and the legacy Company shareholders (who were the owners of the Company’s common stock immediately prior to the Closing) owned an aggregate of 40,875,000 shares, which constituted 25% of the total outstanding Company common stock.

The Company’s and EveryStory’s management agreed, and the A&R Agreement provides, that following the Closing, the Company will conduct a reverse stock split (discussed in more detail below), following which the outstanding shares of the Company’s Series A Preferred Stock will convert into a total of 8,000,000 post-reverse-split common stock. Following such conversion, the EveryStory owners will own or have the right to receive shares of the Company’s common stock equal to 60% of the then-outstanding Company common stock, and the Company legacy shareholders will own shares of the Company’s common stock equal to 40% of the then-outstanding Company common stock, consisting of 8,000,000 shares of Company common stock issued on conversion of the Company’s Series A Preferred Stock (20%) and 8,000,000 shares of the Company’s common stock owned by the other legacy Company shareholders (20%).

As a result of the Closing of the A&R Agreement, EveryStory became a wholly owned subsidiary of the Company. Additionally, the directors and officers of the Company immediately prior to the Closing appointed the EveryStory management to become officers and directors of the Company, and then resigned from their positions with the Company. In addition, the Company terminated its pre-Closing business operations and agreed to dissolve its other wholly owned subsidiary, Knowledge Machine, Inc.

Immediately prior to the Closing, there were 40,875,000 shares of the Company’s common stock. In connection with the Closing, the Company issued an aggregate of 77,377,712 shares to the EveryStory shareholders, and 45,247,288 shares were reserved for issuance to the holders of EveryStory options and convertible debt instruments, and the parties to the A&R Agreement understand and anticipate that all such holders would exercise and convert their securities into the reserved shares of the Company.

On November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. All share numbers provided in this Quarterly Report are given on a post-reverse-split basis.

Accounting Basis

The Company’s financial statements are prepared using the accrual basis of accounting in accordance with U.S. GAAP. As disclosed in a Current Report on Form 8-K filed November 17, 2016, the Company recently changed to a December 31 fiscal year end.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates are made in relation to the allowance for doubtful accounts and the fair value of certain financial instruments.

Principles of Consolidation

The consolidated financial statements include the accounts of Dthera Sciences and its subsidiaries. All significant inter-Company accounts and transactions have been eliminated.

Fair Value of Financial Instruments

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

The following are the hierarchical levels of inputs to measure fair value:

	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

	Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 2.

Embedded Conversion Features

The Company evaluates embedded conversion features within convertible debt under Accounting Standards Codification (“ASC”) 815, "Derivatives and Hedging" to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 "Debt with Conversion and Other Options" for consideration of any beneficial conversion feature.

Derivative Financial Instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.

For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

Debt Issue Costs and Debt Discount

The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.

Stock-Based Compensation

The Company accounts for share based payments in accordance with ASC 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective – Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For this purpose, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders.

Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.

ASC 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this transition method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.

Loss Per Share

Basic loss per Common Share is computed by dividing losses attributable to Common shareholders by the weighted-average number of shares of Common Stock outstanding during the period.

Diluted loss per Common Share is computed by dividing loss attributable to Common shareholders by the weighted-average number of Shares of Common Stock outstanding during the period increased to include the number of additional Shares of Common Stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding convertible Preferred Stock, stock options, warrants, and convertible debt. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s Common Stock can result in a greater dilutive effect from potentially dilutive securities.

For the nine months ended September 30, 2016 and 2015, all of the Company’s potentially dilutive securities (warrants, options, convertible preferred stock, and convertible debt) were excluded from the computation of diluted earnings per share as they were anti-dilutive. The total number of potentially dilutive Common Shares that were excluded were 240,886 and 0 at nine months ended September 30, 2016 and 2015, respectively.

Recent Accounting Pronouncements

Management has considered all other recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

NOTE 4 – PROPERTY AND EQUIPMENT

The Company’s property and equipment were comprised of the following as of September 30, 2016, and December 31, 2015:

	September 30, 2016			December 31, 2015
Computer & Equipment		2,816			2,816
Less: Accumulated Depreciation		(1,880	)		(1,168	)
Net Property and Equipment	$	936		$	1,648

NOTE 5 – ASSET ACQUISITION

On June 5, 2016, EveryStory issued 88,000 pre-split/614,340 post-split new shares for the purchase agreement for an SIT Patent at $0.67 per share for a value of $58,960. The price per share for Common Stock issued was based on the relative fair market value of the Common Stock using the backsolve valuation method.

The Company evaluated this acquisition in accordance with ASC 805, Business Combinations (10-55-4) to discern whether the assets and operations of SIT met the definition of a business. The Company concluded there were not a sufficient number of key processes obtained to develop the inputs into outputs, nor could such processes be easily obtained by the Company. Accordingly, the Company accounted for this transaction as the acquisition of assets.

The transaction was accounted for in accordance with asset acquisition guidance found in ASC 805. The consideration transferred and assets acquired recognized is as follows:

Consideration paid:	$
Common Stock		58,960

Consideration received:	$
Intangible assets		58,960

Net value of assets purchased:		58,960

NOTE 6 – INTANGIBLE ASSETS

The Company’s intangible assets were comprised of the following of September 30, 2016, and December 31, 2015:

	September 30, 2016			December 31, 2015
Technology asset purchase	$	58,960		$	7,100
Less: Accumulated Amortization		–			–
Less: Impairment		(58,960	)		(7,100	)
Net Intangible Assets	$	–		$	–

The Company impaired intangible assets related to the technology asset purchase and patent purchase due to no revenue production, totaling $58,960 and $7,100, for the years ended September 30, 2016 and 2015, respectively.

NOTE 7 – LOANS PAYABLE

Notes Payable – Related Parties

Notes payable due to related parties consisted of the following as of September 30, 2016 and December 31, 2015:

Balance December 31, 2015	$	61,064
Cash additions		94,000
Expense additions		20,627
Cash payments		(80,100	)
Conversions		(95,591	)
Balance September 30, 2016	$	–

During the nine months ended September 30, 2016 and the year ended December 31, 2015, the company Founder and CEO advanced $88,000 and $110,000, and expense additions of $20,627 and $68,904, and was repaid $66,000 and $75,000, respectively. The notes bear an interest rate of 0% per annum.

During the nine months ended September 30, 2016 and the year ended December 31, 2015, the company Founder and CTO advanced $6,000 and $25,000, and expense additions of $0 and $595, and was repaid $14,100 and $73,153, respectively. The notes bear an interest rate of 0% per annum.

On September 21, 2016, the Company’s wholly owned subsidiary (EveryStory) issued 112,690 shares of the EveryStory Series A Preferred Stock to the CEO and CTO in exchange for and as full payment of amounts to them which included $6,096 of accrued expenses, $95,591 of related party loans, $10,000 of convertible notes payable and $1,003 of accrued interest on the convertible notes payable. The EveryStory Series A Preferred stock are redeemable at any time for cash on a dollar-per-dollar basis at a redemption price of $1.00 per share. If not redeemed for cash, the shares of EveryStory Series A Preferred can be convertible into an aggregate of 160,986 shares of common stock, using a conversion price of $0.70 per share pursuant to the A&R Agreement.

Notes Payable

Notes payable consisted of the following as of September 30, 2016, and December 31, 2015:

Balance December 31, 2015	$	–
Cash additions		20,000
Expense additions		–
Cash payments		–
Conversions		–
Balance September 30, 2016	$	20,000

On August 3, 2016, the Company entered into a promissory note purchase agreement with an unrelated individual for $20,000, pursuant to the original version of the Share Exchange Agreement with EveryStory dated July 1, 2016. This note is due on demand. In lieu of interest, the Company issued 10,000 pre-split split shares of the Company’s common stock (69,811 post-split shares of the Company’s common stock) for a value of $6,700.

Convertible Notes Payable – Related Parties

Convertible notes payable due to related parties consisted of the following as of September 30, 2016, and December 31, 2015:

Balance December 31, 2015	$	60,000
Cash additions		–
Expense additions		–
Conversions		(60,000	)
Debt discount from debt issuance costs		–
Balance September 30, 2016	$	–

On June 29, 2015, the Company issued to two related party individuals convertible notes for $30,000 that mature on December 31, 2016. The notes bear an interest rate of 12% per annum and are convertible into shares of the Company’s common stock at the lesser of 70% of the price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $2,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing.

On November 18, 2015, the Company issued to two related party individuals convertible notes for $30,000 that mature on November 18, 2017. The notes bear an interest rate of 12% per annum and are convertible into shares of the Company’s common stock at the lesser of 60% of the lowest price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $5,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing.

On September 21, 2016, in connection with the EveryStory Transaction and the A&R Agreement, the Company's CEO converted the full balance of notes totaling $10,000 of principal and $1,003 of interest, and a director of the Company converted $50,000 of principal and $6,231 of interest into an aggregate of 478,419 shares of the Company’s common stock.

Convertible Notes Payable

Notes payable due to non-related parties consisted of the following as of September 30, 2016, and December 31, 2015:

Balance December 31, 2015	$	465,000
New additions		340,000
Conversions		(656,000	)
Debt discount		(228,822	)
Balance September 30, 2016	$	11,178

On June 29, 2015, the Company issued to ten unrelated individuals convertible notes in the aggregate amount of $195,000 that mature on December 31, 2016. The notes bear an interest rate of 12% per annum and are convertible into shares of the Company’s common stock at the lesser of 70% of the price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $2,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing. On September 21, 2016, all of these convertible notes were converted into common stock based on the terms of the A&R Agreement.

On October 20, 2015, the Company issued to an unrelated individual a convertible note for $5,000 that matures on October 20, 2017. The note bears an interest rate of 12% per annum and is convertible into shares of the Company’s common stock at the lesser of 60% of the lowest price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $5,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing. On September 21, 2016, this convertible note was converted into common stock based on the terms of the A&R Agreement.

On November 18, 2015, the Company issued to eleven unrelated individuals convertible notes in the aggregate amount of $265,000 that mature on November 18, 2017. The notes bear an interest rate of 12% per annum and are convertible into shares of the Company’s common stock at the lesser of 60% of the lowest price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $5,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing. On September 21, 2016, all of these convertible notes were converted into common stock based on the terms of the A&R Agreement.

On February 9, 2016, the Company issued to an unrelated individual two convertible notes for $100,000 that mature on February 9, 2018. The notes bear an interest rate of 0% per annum and are convertible into shares of the Company’s common stock at the $1.60 per share. On September 21, 2016, these convertible notes were converted into common stock based on the terms of the A&R Agreement.

On September 13, 2016, the Company conducted a private offering of convertible notes (the “Note Offering”) to raise additional capital that would remain in the Company following the Closing of the EveryStory Transaction. In the convertible note offering, the Company raised an aggregate of $240,000, which will be a component of the post-Closing capitalization of the Company. In the Note Offering, investors entered into a securities purchase agreement (the “Note SPA”) and were issued a convertible redeemable promissory note (collectively, the “Convertible Notes”). Pursuant to the terms of the Note SPA, each investor represented and warranted that it was an accredited investor and that he or she was purchasing the Convertible Notes for his or her own account, and not with a view to distribution, as well as other standard representations made in private transactions. Also pursuant to the Note SPA, the Company has the right to put an additional Convertible Note (in the same principal amount as purchased by the applicable investor) beginning on January 3, 2017, subject to certain conditions. The Convertible Notes bear interest at a rate of 10%, and mature on September 13, 2017, if not converted or prepaid prior to that. The Convertible Notes convert into shares of the Company's common stock at a price for each share of Common Stock equal to 65% of the lowest closing bid price of the Common Stock as reported on the OTC Market platform on which the Company’s shares are quoted or any exchange upon which the Common Stock may be traded in the future ("Exchange"), on the date of the closing of the EveryStory Transaction. Up to 50% of the Convertible Notes may be repaid by the Company any time prior to 180 days after the issuance of the Convertible Notes, with a 30% premium to be paid in connection with the prepayment.

On September 21, 2016 as part of the EveryStory Transaction, 28 note holders converted promissory notes in the aggregate amount of $565,000 and interest totaling $56,256 into 566,503 pre-split/3,954,836 post-split shares of the Company’s common stock.

For the nine months ended September 30, 2016, conversions of convertible notes into common stock totaled $625,000 and interest totaling $63,713, converted into 635,033 pre-split/4,433,255 post-split shares of the Company’s common stock.

NOTE 8 –DERIVATIVE LIABILITIES

Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has four liability measured at fair value on a recurring basis, which consists of a derivative liability on certain convertible notes payable (see note 7). As of September 30, 2016 this derivative liability had an estimated fair value of $191,949. The Company has no assets that are measured at fair value on a recurring basis.

The following table presents information about our derivative liability, which was our only financial instrument measured at fair value on a recurring basis using significant inputs other than level one inputs that are either directly or indirectly observable (Level 2) as of September 30, 2016:

Balance at December 31, 2015	$	–
Issuances		260,197
Change in Fair Value of Derivative		(68,248	)
Balance at September 30, 2016	$	191,949

The fair value of this derivative liability was calculated using the multinomial lattice models that value the derivative liability within the notes based on a probability weighted discounted cash flow model. These models are based on future projections of the various potential outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion feature with the reset provisions; redemption provisions; and the default provisions. Assumptions used to calculate the fair value of the derivative liability were as follows:

	September 30,
	2016
Expected term in years	1.00 - 0.95 years
Risk-free interest rates		0.56 - 0.63%
Volatility		103.83 - 176.59%
Dividend yield		0%

In addition to the assumptions above, the Company also takes into consideration whether or not the Company would participate in another round of financing and if that financing is registered or not and what that stock price would be for the financing at that time. The Company notes that the notes have matured and is no longer calculating a derivative value for these notes.

NOTE 9 –PREFERRED STOCK

Preferred Shares – EveryStory Inc.

The Company’s subsidiary, EveryStory, Inc. (“EveryStory”), has authorized 10,000,000 shares of $0.0001 par value per share Preferred Stock, of which 112,690 and 0 units were issued and outstanding as of September 30, 2016, and December 31, 2015, respectively.

On September 21, 2016, EveryStory issued 112,690 shares of the EveryStory Series A Preferred Stock to the CEO and CTO in exchange for and as full payment of amounts to them which included $6,096 of accrued expenses, $95,591 of related party loans, $10,000 of convertible notes payable and $1,003 of accrued interest on the convertible notes payable. The EveryStory Series A Preferred stock are redeemable at any time for cash on a dollar-per-dollar basis at a redemption price of $1.00 per share. If not redeemed for cash, the shares of EveryStory Series A Preferred can be converted into an aggregate of 160,986 shares of common stock of EveryStory (using a conversion price of $0.70 per share pursuant to the A&R Agreement), which then would be automatically converted into shares of the Company’s Common Stock, per the A&R Agreement.

Preferred Shares – Dthera Sciences

The Company has authorized 10,000,000 shares of $0.001 par value per share Preferred Stock, of which no shares were issued and outstanding as of the date of this Report.

Series A Convertible Preferred Stock

The Company authorized to issue 1,000,000 preferred shares, par value $0.001 per share, including 150,000 of which were designated as Series A Shares. The Series A Shares have the following rights and preferences:

The Series A Shares are convertible into shares of the Company’s Common Stock at any time at a conversion rate of 80 shares of Common Stock for each Series A Share converted, subject to adjustments in the event of stock splits, recapitalizations, or similar events, provided that the Series A Shares will not be adjusted for any reverse stock split for a period of one year from the filing date of the Certificate of Designations creating the series, which is intended to occur with the first sale of Series A Shares in this offering.

The Series A Shares are entitled to the number of votes equal to the number of whole shares of Common Stock into which the Series A Shares are convertible and vote together with the holders of the Common Stock, except as otherwise required by Nevada law or as provided in the Certificate of Designations for the Series A Shares.

	·	A majority vote of the outstanding Series A Shares voting as a single class is required for any of the following actions:

	o	Any alteration, amendment, or change in the rights, preferences or privileges of the Series A Shares;

	o	Any amendment to the Company’s Certificate of Incorporation or Bylaws that would impair or reduce the rights of the Series A Shares; and

Any transaction resulting in the redemption of any of the Company’s securities.

In the event of any voluntary or involuntary liquidation, dissolution or winding up of our Company (including a disposition of substantially all of our assets, whether by sale, merger or other reorganization, or a sale of over 50% of the ownership of the Company), the holders of the Series A Shares will be entitled to receive the greater of 150% of the purchase price of the Series A Shares, plus accrued dividends, if any, or the amount distributed to the holders of the Common Stock as though the Series A Shares were converted. Liquidating distributions will be in preference to the holders of Common Stock.

The holders of the Series A Shares are not entitled to preference over the common shares on dividends, if any, declared by the Board.

There are no redemption or sinking fund provisions applicable to the Series A Shares.

Pursuant to the terms of the A&R Agreement, following the effectiveness of the Reverse Split, all of the outstanding shares of the Company’s Series A Preferred Stock were converted into an aggregate of 160,986 shares of common stock of EveryStory (using a conversion price of $0.70 per share pursuant to the A&R Agreement), which then would be automatically converted into shares of the Company’s common stock, per the A&R Agreement.

NOTE 10 – COMMON STOCK

The Company (Dthera) has authorized 200,000,000 shares of $0.001 par value per share Common Stock, of which 5,729,722 pre-split/40,000,000 post-split shares and 2,050,000 pre-split/14,311,341 post-split shares were issued outstanding as of September 30, 2016, and December 31, 2015, respectively.

On February 23, 2016, EveryStory amended its Certificate of Incorporation to increase the number of authorized shares to 100,000,000. The activity surrounding the issuances of the Common Stock by EveryStory is as follows:

Nine months Ended September 30, 2016

EveryStory issued 436,321 shares of EveryStory’s common stock for the services value of $41,875 and recorded a $34,875 gain on extinguishment of debt. EveryStory issued 614,340 shares of EveryStory’s common stock for the purchase agreement for an SIT Patent for a value of $58,960. The price per share for Common Stock issued for services was based on the relative fair market value of the Common Stock using the backsolve valuation method.

On September 21, 2016 as part of the A&R Agreement, EveryStory issued 635,055 pre-split/4,433,255 post-split shares of EveryStory’s common stock for the conversion of debt for a value of $730,174, and issued 10,000 pre-split/69,811 post split shares of EveryStory’s common stock in lieu of interest for a value of $6,700. EveryStory also issued 592,300 pre-split/4,134,930 post-split shares of EveryStory’s common stock for the conversion of 592,300 options. The Company exchanged 16,000,000 post-split shares of the Company’s common stock as part of the agreement totaling $56,355.

Year Ended December 31, 2015

EveryStory issued 900,000 pre-split/6,283,028 post-split shares of EveryStory Common Stock for net cash proceeds of $10,000 to Company founders. EveryStory also issued 50,000 pre-split/349,057 post-split shares of Common Stock as payment for services at $0.67 per share for a value of $33,500. The price per share for Common Stock issued for services was based on the relative fair market value of the Common Stock using the backsolve valuation method.

NOTE 11 – STOCK PURCHASE OPTIONS

In 2015, the Board of Directors of EveryStory approved the adoption of the EveryStory’s Stock Option Plan (“the Plan”). The purpose of the Plan is to advance the interests of EveryStory by encouraging and enabling acquisition of a financial interest in EveryStory by employees, consultants, and other key individuals. The Plan is intended to aid EveryStory in attracting and retaining key employees, to stimulate the efforts of such individuals and to strengthen their desire to remain with EveryStory. A maximum of 680,000 shares of EveryStory's Common Stock is reserved for issuance under stock options to be issued under the Plan. The Plan permits the grant of incentive stock options, non-statutory stock options and restricted stock awards. The Plan is administered by the Board of Directors or, at its direction, a Compensation Committee comprised of officers of EveryStory.

Stock Purchase Options

During the nine months ended September 30, 2016, EveryStory issued options to purchase a total of 106,100 valued at $63,678 with multiple vesting periods. EveryStory issued the options in conjunction with employment agreements. The price per share for Common Stock for the stock options was based on the relative fair market value of the Common Stock using the backsolve valuation method of applying the Option Pricing Method (OPM).

During the year ended December 31, 2015, EveryStory issued options to purchase a total of 486,200 shares of Common Stock valued at $75,457 with multiple vesting periods. EveryStory issued 127,200 options in conjunction to a consulting agreement entered into in May 10, 2015 and 359,000 options issued in conjunction with employment agreements entered into during the year. The options were valued using the Black-Scholes options pricing model under the assumptions noted below. The price per share for Common Stock for the stock options was based on the relative fair market value of the Common Stock using the backsolve valuation method of applying the Option Pricing Method (OPM).

The following table summarizes the changes in options outstanding of the Company during the nine months ending September 30, 2016:

	Number of Options			Weighted Average Exercise Price $
Outstanding, December 31, 2015		486,200			0.67
Granted		106,100			0.67
Converted		(592,300	)		–
Outstanding, September 30, 2016		–			–

Exercisable, September 30, 2016		–			–

As of September 21, 2016 all EveryStory options were converted to the Company’s common stock as part of the share purchase agreement. As of September 30, 2016, the Company had $0 in unrecognized expense related to future vesting of stock options.

NOTE 12 – FAIR VALUE MEASUREMENTS

Liabilities measured at fair value on a recurring basis at September 30, 2016, are summarized as follows:

	Level 1		Level 2		Level 3		Total
Fair value of options	$	–	$	–	$	–	$	–
Fair value of derivatives	$	–	$	191,949	$	–	$	191,949

Liabilities measured at fair value on a recurring basis at December 31, 2015, are summarized as follows:

	Level 1		Level 2		Level 3		Total
Fair value of options	$	–	$	75,457	$	–	$	75,457
Fair value of derivatives	$	–	$	–	$	–	$	–

Fair value is calculated using the Black-Scholes options pricing model.

NOTE 13- SUBSEQUENT EVENTS

In accordance with ASC 855, Company’s management reviewed all material events through the date of this filing and determined that there were the following material subsequent events to report:

Reverse Stock Split; Conversion of Outstanding Knowledge Machine Series A Preferred Stock

On November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. In lieu of issuing fractional shares, the Company’s transfer agent was instructed to round up to the nearest whole share.

Immediately following the effectiveness of the Reverse Split, the Company’s 100,000 outstanding shares of Series A Preferred Stock were converted, pursuant to their terms, into 8,000,000 shares of post-Reverse Split common stock. Additionally, through the application of the Reverse Split, the 40,875,000 shares of common stock held by the legacy shareholders of Knowledge Machine following the closing of the EveryStory Transaction and immediately prior to the Reverse Split became 8,000,000 shares of common stock. Accordingly, the legacy shareholders of Knowledge Machine International, including the holders of the shares of Series A Preferred Stock, owned an aggregate of 16,000,000 shares of the Company’s common stock. The shares of the Company’s common stock held by the former EveryStory Shareholders went from 77,377,712 to 15,144,262 shares by virtue of the Reverse Split, with an additional 8,855,738 shares of the Company’s common stock reserved for issuance to the holders of EveryStory convertible instruments, including convertible notes, options, and other derivative securities.

Following the Reverse Split, the Company had 35,853,007 shares of common stock outstanding, consisting of 27,853,007 shares outstanding resulting from the Reverse Split, and the 8,000,000 shares of the Company’s common stock issued on conversion of the prior KMI Series A Preferred Stock immediately following the Reverse Split.

The Reverse Split was approved by the Board of Directors and the shareholders of the Company prior to the closing of the EveryStory Transaction, which approval was included in the closing conditions to the EveryStory Transaction.

Name Change; Ticker Symbol Change Requested

In connection with the closing of the EveryStory Transaction and the divestiture of the prior business and operations of the Company, as well as the new focus of the Company on the digital therapeutics and reminiscence therapy focus of the Company, the Board of Directors and the majority shareholders of the Company immediately following the closing of the EveryStory Transaction approved an amendment to the Company’s Articles of Incorporation to change the name of the Company (the “Name Change”) from Knowledge Machine International, Inc., to Dthera Sciences. The Name Change took effect at the same time as the Reverse Split on November 2, 2016.

In connection with the Name Change, and to help current shareholders and new investors better understand the business of the Company, the Company requested that a new ticker symbol be assigned to the Company. The Company has requested “DTHR” as the new ticker symbol, which will take effect twenty business days following the effectiveness of the Reverse Split (per FINRA rules).

New Website

Additionally, the Company launched a new website, www.dthera.com, to provide information about the Company, its business and operations, and additional information about digital therapeutics and reminiscence therapy. The link provided is for informational purposes only, and no information contained on the Company’s website should be deemed to be part of this or any filing of the Company.

Commencement of Clinical Trial

During November 2016, the University of California at San Diego began the previously disclosed clinical trial of the use of the EveryStory Platform as a Digital Therapeutic and Reminiscence Therapy treatment for patients with Alzheimer’s disease and other diagnoses of dementia. The Company anticipates that the clinical trial will be completed during the first quarter of 2017, and the Company will announce the results of the trial upon its completion.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Management’s Discussion and Analysis of Financial Condition and Results of Operations analyzes the major elements of our balance sheets and statements of income. This section should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2016, and our interim financial statements and accompanying notes to these financial statements. All amounts are in U.S. dollars.

Forward-Looking Statement Notice

This quarterly report on Form 10-Q of Dthera Sciences (formerly Knowledge Machine International, Inc.) (the “Company”) contains forward-looking statements about our expectations, beliefs or intentions regarding, among other things, our product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, we or our representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as “believe,” “expect,” “intend,” “plan,” “may,” “should” or “anticipate” or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by us with the SEC, press releases or oral statements made by or with the approval of one of our authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, those set forth in our most recent annual report referenced below.

This report identifies important factors which could cause our actual results to differ materially from those indicated by the forward-looking statements, particularly those set forth under Item 1A – Risk Factors as disclosed in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission on October 13, 2016.

All forward-looking statements attributable to us or persons acting on our behalf speak only as of the date of this report and are expressly qualified in their entirety by the cautionary statements included in this report. We undertake no obligations to update or revise forward-looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. In evaluating forward-looking statements, you should consider these risks and uncertainties.

Transition Report – Explanatory Note

As reported by the Company in a Current Report filed with the Commission on September 27, 2016, the Company closed a transaction whereby it acquired 100% of the outstanding stock of EveryStory, Inc., a Delaware corporation (“EveryStory”). The transaction is referred to in this Quarterly Report as the “EveryStory Transaction.”

Overview

On September 21, 2016, the Company acquired a new operating subsidiary, EveryStory, Inc., a Delaware corporation (“EveryStory”). EveryStory offers a subscription-based service that captures, shares, and stores photos and audio in cloud. It offers the EveryStory platform, which enables users to preserve and share memories, and will initially target a Quality of Life benefit in certain patient populations, principally patients suffering from Alzheimer’s disease and dementia. As of the date of this Report, EveryStory was our only subsidiary. Additional information relating to the business and operations of EveryStory, which will become our business and operations, is given below. Prior to the closing of the transaction with EveryStory (the “EveryStory Transaction”), the Company had been incorporated in the State of Nevada on December 27, 2012, to engage in the development and operation of a business engaged in the distribution of high end edged tools produced outside the US. The Company conducted this business through October 22, 2014. On October 22, 2014, the Company acquired an operating subsidiary, Knowledge Machine, Inc., a Nevada corporation, (“Knowledge Machine”), which focused on new technologies, acquiring licensing rights to those technologies, and marketing the licensed technologies, and the Company sold off the edged tools business. In connection with the EveryStory Transaction, the Company dissolved Knowledge Machine, and terminated the technology licensing and marketing operations.

Subsequent to the closing of the EveryStory Transaction, the Company effectuated a reverse stock split of its outstanding common stock, changed its name from Knowledge Machine International to Dthera Sciences, and requested a new ticker symbol, which should take effect in late November 2016. Additional information about these events is included below under the heading “Recent Developments.”

Our principal offices are located at 7310 Miramar Rd., San Diego, CA 92126, and our mailing address is 9921 Carmel Mountain Road, Suite 118, San Diego, CA 92129.

The Company qualifies as an “emerging growth company” as defined in the Jumpstart our Business Startups Act (the “JOBS Act”).

Plan of Operations

By way of background, EveryStory, Inc., a Delaware corporation, was founded on September 5, 2013. From inception until EveryStory formally launched operations in January 2014, EveryStory was a development stage company. Following the closing of the EveryStory Transaction, EveryStory became a wholly owned subsidiary of the Company, which divested itself of its former business and operations, and will focus on the business and operations of Digital Therapeutics and Reminiscence Therapy using the EveryStory Platform going forward. References herein to “EveryStory” relate to the wholly owned Delaware corporation subsidiary. References to the “Company,” or “we,” “our,” or “us,” refer to the publicly reporting company, Dthera Sciences, formerly Knowledge Machine International, Inc., with the understanding that Dthera Sciences will be implementing the business, operations, and plans of EveryStory.

Overview – The Platform

EveryStory began as a digital image story-sharing platform (the “Platform”) that allowed users to collaboratively create, preserve and share personal stories within a private group.

David Keene is the Chief Technical Officer and Founder of EveryStory. In his words: “I created EveryStory after being diagnosed with colon cancer and realizing my son might never remember my voice or hear my stories. I am passionate about providing people with an innovative way to preserve and share memories forever in the most interactive way possible.” Mr. Keene was successfully treated in 2012, and is now healthy and cancer-free.

Key components of the Platform include the ability to record audio narratives that are linked to specific photos and which can be played when the photos are viewed; the ability to import photos directly from computers or mobile devices; cloud-based data storage of the photos and the audio recordings; and multiple playback capabilities; collaborative creation and sharing of stories. The Platform was designed for mobile device platforms to enable users to record and store photos and audio easily and conveniently.

Application of the Platform – Digital Therapeutics and Reminiscence Therapy

Dthera’s management is focused on the goal of using EveryStory’s technology Platform, which streamlines the creation of personalized digital stories, to become the first clinically-proven Digital Therapeutic delivering Reminiscence Therapy to patients with Alzheimer's disease and Dementia. EveryStory already has a granted US patent (issued in 2010) that broadly covers the use of EveryStory’s technology in Senior Living facilities. EveryStory recently commenced a clinical trial with the University of California at San Diego (“UCSD”) showing that EveryStory is an effective anxiety reduction and quality of life therapy for those with Alzheimer’s disease or Dementia (“ADOD”).

In connection with this application of the Platform, EveryStory is focusing on the developing fields of Digital Therapeutics and Reminiscence Therapy.

Results of Operations –Three Months Ended September 30, 2016 Compared to the Three Months Ended September 30, 2015

Gross Revenue. Gross revenue for the three months ended September 30, 2016 and 2015 was $0. Accordingly, there were no costs of goods sold. The Company was previously operating in the cutlery sales market but that business was sold and a new operating subsidiary was acquired which is operating in the technology market. This new line of business is in the development stage and has not yet recognized any revenue.

Operating Expenses

General and Administrative Expenses

General and administrative expenses for the three months ended September 30, 2016 totaled $136,209, a 23% decrease compared to general and administrative expenses of $177,010 for the three months ended September 30, 2015. The decrease is due to the Company’s issuing stock and options as compensation in the prior three month period.

Professional fees

Professional fees for the for the three months ended September 30, 2016 totaled $183,312, a 391% increase compared to professional fees of $37,317 for the three months ended September 30, 2015. The increase is due to the Company’s preparing for the EveryStory Transaction and performing an audit in the current period.

Other Expenses

Interest Expenses

Interest expenses for the three months ended September 30, 2016, totaled $32,962, a 384% increase compared to interest expenses of $6,805 for the three months ended September 30, 2015. The increase is due to more notes accruing interest and the amortization of debt discounts in the current period.

Derivative Expense

Derivative expense for the three months ended September 30, 2016, totaled $30,197, a 100% increase compared to derivative expense of $0 for the three months ended September 30, 2015. The increase is due to the Company’s entering into four derivative instruments during the current period.

Gain on Derivative Liabilities

Gain on Derivative Liabilities for the three months ended September 30, 2016, totaled $68,248, a 100% increase compared to gain on derivative liabilities of $0 for the three months ended September 30, 2015. The increase is due to the Company’s entering into four derivative instruments during the current period.

Gain on Settlement of Debt

Gain on settlement of debt for the three months ended September 30, 2016, totaled $34,875, a 100% increase compared to gain on settlement of debt of $0 for the three months ended September 30, 2015. The increase is due to the Company’s entering into converting debt as part of the EveryStory Transaction during the current period.

Net Loss. For the reasons stated above, the Company’s net loss for the three months ended September 30, 2016, was $279,796, compared to net loss of $221,132 during the three months ended September 30, 2015.

Results of Operations –Nine Months Ended March 31, 2016 Compared to the Nine Months Ended March 31, 2015

Gross Revenue. Gross revenue for the nine months ended September 30, 2016 and 2015 was $0. Accordingly, there were no costs of goods sold. The Company was previously operating in the cutlery sales market but that business was sold and a new operating subsidiary was acquired which is operating in the technology market. This new line of business is in the development stage and has not yet recognized any revenue.

Operating Expenses

General and Administrative Expenses

General and administrative expenses for the nine months ended September 30, 2016 totaled $388,402, a 50% increase compared to general and administrative expenses of $259,229 for the nine months ended September 30, 2015. The increase is due to the Company’s issuing stock and options as compensation, consulting fees, and investor relations in the current period.

Professional fees

Professional fees for the for the nine months ended September 30, 2016 totaled $212,464, a 54% increase compared to professional fees of $137,934 for the nine months ended September 30, 2015. The increase is due to the Company’s preparing for the EveryStory Transaction and performing an audit in the current period.

Other Expenses

Interest Expenses

Interest expenses for the nine months ended September 30, 2016, totaled $68,800, a 890% increase compared to interest expenses of $6,953 for the nine months ended September 30, 2015. The increase is due to more notes accruing interest and the amortization of debt discounts in the current period.

Derivative Expense

Derivative expense for the nine months ended September 30, 2016, totaled $30,197, a 100% increase compared to derivative expense of $0 for the three months ended September 30, 2015. The increase is due to the Company’s entering into four derivative instruments during the current period.

Gain on Derivative Liabilities

Gain on Derivative Liabilities for the nine months ended September 30, 2016, totaled $68,248, a 100% increase compared to gain on derivative liabilities of $0 for the three months ended September 30, 2015. The increase is due to the Company’s entering into four derivative instruments during the current period.

Gain on Settlement of Debt

Gain on settlement of debt for the nine months ended September 30, 2016, totaled $34,875, a 100% increase compared to gain on settlement of debt of $0 for the three months ended September 30, 2015. The increase is due to the Company’s entering into converting debt as part of the EveryStory Transaction during the current period.

Impairment of Intangible Assets

Impairment of Intangible Assets for the nine months ended September 30, 2016, totaled $58,960, a 100% increase compared to Impairment of Intangible Assets of $0 for the nine months ended September 30, 2015. The increase is due to the Company’s impairing the intangible asset purchase with stock in the current period.

Net Loss. For the reasons stated above, the Company’s net loss for the nine months ended September 30, 2016, was $656,412, compared to net loss of $404,116 during the nine months ended September 30, 2015.

Liquidity and Capital Resources

As of September 30, 2016, the Company had cash of $115,532 and prepaid expenses of $5,000, and deposits of $1,000. The Company had current liabilities of $363,087 consisting of accounts payable and accounts payable, derivative liabilities, and convertible debt. As of September 30, 2016, the Company had a working capital deficit of $240,620.

The accompanying financial statements have been prepared contemplating a continuation of the Company as a going concern. The Company had ongoing operations during from inception to September 30, 2016, with an accumulated deficit of $1,440,008.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our consolidated financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity capital expenditures or capital resources.

Recent Developments

Reverse Stock Split; Conversion of Outstanding Knowledge Machine Series A Preferred Stock

On November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. In lieu of issuing fractional shares, the Company’s transfer agent was instructed to round up to the nearest whole share.

Name Change; Ticker Symbol Change Requested

New Website

Commencement of Clinical Trial

During November 2016, the University of California at San Diego began the previously disclosed clinical trial of the use of the EveryStory Platform as a Digital Therapeutic technology and Reminiscence Therapy treatment for patients with Alzheimer’s disease and other diagnoses of dementia. The Company anticipates that the clinical trial will be completed during the first fiscal quarter of 2017, and the Company will announce the results of the trial upon its completion.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, the Company is not required to provide the disclosure required by this item.

Item 4. Controls and Procedures

Evaluation of disclosure controls and procedures

Our management, with the participation of our Chief Executive Officer who is also our principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 15(d)-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were not effective in ensuring that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (ii) is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. As of the end of the period covered by the Report, we did not have a formal audit committee and there was a lack of segregation of duties.

Changes in internal control over financial reporting

There has been no change in our internal control over financial reporting, as defined in Rules 13a-15(f) of the Exchange Act, during our most recent fiscal quarter ended September 30, 2016, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1A. Risk Factors

See “Item 1A – Risk Factors” as disclosed in Form 10-K as filed with the Commission on October 13, 2016, as well as those included in the Company’s Current Report on form 8-K filed with the Commission on November 4, 2016.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

As noted above and as previously disclosed, on September 21, 2016, the Company entered into an Amended and Restated Acquisition and Share Exchange Agreement (the “A&R Agreement”) with EveryStory and each of its shareholder (the “Shareholders”), and closed the acquisition (the “Acquisition”) of the ownership of EveryStory (the “Closing”).

Pursuant to the A&R Agreement, the Company issued an aggregate of 19,853,007 shares of the Company’s common stock to the EveryStory holders and the holders of EveryStory convertible debt which converted automatically at the closing of the EveryStory Transaction, with the understanding that an additional 4,146,993 shares were to be reserved for issuance to holders of EveryStory options which are exercisable into shares of EveryStory common stock (collectively, the “Exchange Shares”). (As noted above, on November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. All share numbers provided in this Quarterly Report are given on a post-reverse-split basis.)

Additionally, prior to Closing, the Company conducted a non-public offering of its Series A Convertible Preferred stock (the “Preferred Stock Offering”) to raise up to $120,000 for operating funds for KMI and to satisfy accounts payable prior to Closing. One Hundred Thousand shares of KMI Series A Preferred Stock were sold in the Preferred Stock Offering. The KMI Series A Preferred Stock converted into an aggregate of 8,000,000 shares of the Company’s common stock immediately following the effectiveness of the Reverse Split. Pursuant to the Preferred Stock Offering, each investor entered into a subscription agreement pursuant to which each investor represented and warranted that it was an accredited investor and that he or she was purchasing the Preferred Stock for his or her own account, and not with a view to distribution, as well as other standard representations made in private transactions.

Further, the Company conducted a private offering of convertible notes (the “Note Offering”) to raise additional capital that would remain in the Company following the Closing of the EveryStory Transaction. In the Note Offering, investors entered into a securities purchase agreement (the “Note SPA”) and were issued a convertible redeemable promissory note (collectively, the “Convertible Note”). Pursuant to the terms of the Note SPA, each investor represented and warranted that it was an accredited investor and that he or she was purchasing the Convertible Note for his or her own account, and not with a view to distribution, as well as other standard representations made in private transactions. Also pursuant to the Note SPA, the Company has the right to put an additional Convertible Note (in the same principal amount as purchased by the applicable investor) beginning on January 3, 2017, subject to certain conditions. The Convertible Notes bear interest at a rate of 10%, and mature on September 13, 2017, if not converted or prepaid prior to that. The Convertible Notes are convertible into shares of the Company’s common stock at a conversion price of $0.195, subject to adjustment as described in the Convertible Note. Up to 50% of the Convertible Notes may be repaid by the Company any time prior to 180 days after the issuance of the Convertible Notes, with a 30% premium to be paid in connection with the prepayment.

Based on the terms of the Convertible Notes, absent any adjustment of the conversion price, the Company could be required to issue up to approximately 240,995 shares of the Company’s common stock if the entire principal amounts of the Convertible Notes were converted. The Company could be required to issue additional shares of its common stock if interest accruing on the Convertible Notes is converted into shares (on the same formula as that of the Convertible Notes), although as of the date of this Report, the Company could not determine how many shares could be issued until such conversions occur.

The securities offered and sold by the Company in the non-public offerings (both the preferred stock and the convertible note offerings) and in the exchange transition with the shareholders of EveryStory have not been and will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

The non-public offerings (both the preferred stock and the convertible note offerings) and in the exchange transition with the shareholders of EveryStory were made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act and/or the private offering safe harbor provisions of Rule 506 of Regulation D based on the following factors: (i) the number of offerees or purchasers, as applicable, (ii) the absence of general solicitation, (iii) investment representations obtained from the security holders in each of the transactions, (iv) the provision of appropriate disclosure, and (v) the placement of restrictive legends on the certificates reflecting the securities.

Item 5. Other Information.

Change in Auditors

As previously disclosed, on November 8, 2016, the Board of Directors of the Company terminated Pritchett Siler & Hardy, P.C. (“PSH”), as the Company’s independent public accounting firm. The termination of PSH was not due to any disagreement with PSH over accounting or other issues, but was done in connection with the closing of the EveryStory Transaction and the change in focus of the Company’s business. Also on November 8, 2016, the Board of Directors of the Company engaged Sadler Gibb & Associates, LLC (“Sadler Gibb”) as the Company’s new independent public accounting firm. Sadler Gibb had previously audited EveryStory’s financial statements in connection with the EveryStory Transaction.

Change in Fiscal Year End

Also as previously disclosed, on November 12, 2016, the Board of Directors of the Company changed the fiscal year of the Company from June 30 to December 31. This report includes an explanatory note relating to the change in fiscal year and the Company’s reporting to the Commission on transition reports.

Item 6. Exhibits

SEC Ref. No.	Title of Document
31.1	Certification by Principal Executive and Financial Officer
32.1	Certification of Principal Executive and Financial Officer
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Dthera Sciences

Date: November 21, 2016	By:	/s/ Edward Cox
		Edward Cox Chief Executive Officer, Chief Financial Officer (Principal Executive Officer and Principal Financial Officer)

GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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end EX-31.1 3 dthera_ex3101.htm CERTIFICATION

Exhibit 31.1

Certification

I, Edward Cox, certify that:

1. I have reviewed this Form 10-Q quarterly report of Dthera Sciences for the quarter ended September 30, 2016;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 21, 2016

/s/ Edward Cox

Edward Cox

Chief Executive Officer, Chief Financial Officer (Principal Executive Officer and Principal Financial Officer)

EX-32.1 4 dthera_ex3201.htm CERTIFICATION

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Dthera Sciences (the “Company”) on Form 10-QT for the quarter ended September 30, 2016, as filed with the Securities and Exchange Commission (the “Report”), the undersigned principal executive and financial officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 21, 2016

/s/ Edward Cox

Edward Cox

Chief Executive Officer, Chief Financial Officer (Principal Executive Officer and Principal Financial Officer)

EX-101.INS 5 sddl-20160930.xml XBRL INSTANCE FILE 0001586372 2016-01-01 2016-09-30 0001586372 2016-11-21 0001586372 2016-09-30 0001586372 2015-12-31 0001586372 2016-07-01 2016-09-30 0001586372 2015-07-01 2015-09-30 0001586372 2015-01-01 2015-09-30 0001586372 2014-12-31 0001586372 2015-09-30 0001586372 2015-01-01 2015-12-31 0001586372 SDDL:NotesPayableRelatedPartiesMember 2016-01-01 2016-09-30 0001586372 SDDL:NotesPayableRelatedPartiesMember 2016-09-30 0001586372 SDDL:NotesPayableRelatedPartiesMember 2015-12-31 0001586372 SDDL:NotesPayableMember 2016-01-01 2016-09-30 0001586372 SDDL:NotesPayableMember 2016-09-30 0001586372 SDDL:NotesPayableMember 2015-12-31 0001586372 SDDL:ConvertibleNotesPayableRelatedPartiesMember 2016-01-01 2016-09-30 0001586372 SDDL:ConvertibleNotesPayableRelatedPartiesMember 2016-09-30 0001586372 SDDL:ConvertibleNotesPayableRelatedPartiesMember 2015-12-31 0001586372 us-gaap:ConvertibleNotesPayableMember 2016-01-01 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember 2015-12-31 0001586372 SDDL:NotesPayableRelatedPartiesMember SDDL:FounderCEOMember 2016-01-01 2016-09-30 0001586372 SDDL:NotesPayableRelatedPartiesMember SDDL:FounderCEOMember 2015-01-01 2015-12-31 0001586372 SDDL:NotesPayableRelatedPartiesMember SDDL:FounderCEOMember SDDL:EveryStorySeriesAMember 2016-01-01 2016-09-30 0001586372 SDDL:NotesPayableRelatedPartiesMember SDDL:FounderCEOMember SDDL:AccruedExpensesMember 2016-01-01 2016-09-30 0001586372 SDDL:NotesPayableRelatedPartiesMember SDDL:FounderCEOMember SDDL:RelatedPartyLoansMember 2016-01-01 2016-09-30 0001586372 SDDL:NotesPayableRelatedPartiesMember SDDL:FounderCEOMember us-gaap:ConvertibleNotesPayableMember 2016-01-01 2016-09-30 0001586372 SDDL:NotesPayableRelatedPartiesMember SDDL:FounderCEOMember SDDL:AccruedInterestMember 2016-01-01 2016-09-30 0001586372 SDDL:NotesPayableMember SDDL:UnrelatedIndividualMember 2016-01-01 2016-09-30 0001586372 SDDL:ConvertibleNotesPayableRelatedPartiesMember SDDL:TwoIndividualsMember 2016-01-01 2016-09-30 0001586372 SDDL:ConvertibleNotesPayableRelatedPartiesMember SDDL:TwoIndividualsMember 2016-09-30 0001586372 SDDL:ConvertibleNotesPayableRelatedPartiesMember SDDL:TwoIndividuals2Member 2016-01-01 2016-09-30 0001586372 SDDL:ConvertibleNotesPayableRelatedPartiesMember SDDL:TwoIndividuals2Member 2016-09-30 0001586372 SDDL:NotesPayableRelatedPartiesMember SDDL:FounderCTOMember 2016-01-01 2016-09-30 0001586372 SDDL:NotesPayableRelatedPartiesMember SDDL:FounderCTOMember 2015-01-01 2015-12-31 0001586372 us-gaap:ChiefExecutiveOfficerMember SDDL:EveryStorySeriesAMember 2016-01-01 2016-09-30 0001586372 us-gaap:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2016-01-01 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember SDDL:TenIndividualsMember 2016-01-01 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember SDDL:TenIndividualsMember 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember SDDL:UnrelatedIndividualMember 2016-01-01 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember SDDL:UnrelatedIndividualMember 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember SDDL:UnrelatedIndividual2Member 2016-01-01 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember SDDL:UnrelatedIndividual2Member 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember SDDL:NoteOfferingMember 2016-01-01 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember SDDL:Note28Member SDDL:EveryStoryTransactionMember 2016-01-01 2016-09-30 0001586372 us-gaap:ConvertibleNotesPayableMember SDDL:TotalConversionsMember 2016-01-01 2016-09-30 0001586372 SDDL:ConvertibleNotesMember 2016-01-01 2016-09-30 0001586372 SDDL:ConvertibleNotesMember 2015-12-31 0001586372 SDDL:PreSplitMember 2016-09-30 0001586372 SDDL:PreSplitMember 2015-12-31 0001586372 SDDL:PostSplitMember 2016-09-30 0001586372 SDDL:PostSplitMember 2015-12-31 0001586372 SDDL:EveryStoryMember us-gaap:CommonStockMember 2016-01-01 2016-09-30 0001586372 SDDL:PreSplitMember SDDL:EveryStoryMember 2016-01-01 2016-09-30 0001586372 SDDL:PostSplitMember SDDL:EveryStoryMember 2016-01-01 2016-09-30 0001586372 SDDL:PreSplitMember SDDL:EveryStoryMember SDDL:InterestConvertedMember 2016-01-01 2016-09-30 0001586372 SDDL:PostSplitMember SDDL:EveryStoryMember SDDL:InterestConvertedMember 2016-01-01 2016-09-30 0001586372 SDDL:DtheraSciencesMember us-gaap:CommonStockMember 2016-01-01 2016-09-30 0001586372 SDDL:StockOptionsMember 2016-01-01 2016-09-30 0001586372 SDDL:StockOptionsMember 2016-09-30 0001586372 SDDL:StockOptionsMember 2015-12-31 0001586372 SDDL:StockOptionsMember SDDL:EveryStoryMember 2016-01-01 2016-09-30 0001586372 SDDL:StockOptionsMember SDDL:EveryStoryMember 2016-09-30 0001586372 SDDL:StockOptionsMember SDDL:EveryStoryMember 2015-01-01 2015-12-31 0001586372 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2016-09-30 0001586372 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2015-12-31 0001586372 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2016-09-30 0001586372 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2015-12-31 0001586372 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2016-09-30 0001586372 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2015-12-31 0001586372 us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001586372 us-gaap:FairValueMeasurementsRecurringMember 2015-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure Dthera Sciences 0001586372 10-QT 2016-09-30 false --12-31 No No Yes Smaller Reporting Company Q3 2016 40000000

115531

27238

5000

21390

1000

121531

49628

936

1648

936

1648

122467

51276

139960

149965

17993

191949

61064

11178

189243

0 29114

363087

447379

270000

0 30000

300000

363087

747379

40000

14311

1159377

73182

-1440008

-783596

-240620

-696103

122467

51276

0.001

1000000

112690

0.001

200000000

100000000

40000000

14353091

40000000

14353091

5729722

40000000

2050000

14311341

712

239

388402

136209

177010

259229

212464

183312

37317

137934

601578

319760

214327

397163

-601578

-319760

-214327

-397163

68800

32962

6805

6953

30197

68248

34875

58960

7100

-54834

39964

-6805

-6953

-656412

-279796

-221132

-404116

15512115

17713943

14774889

11852384

-0.04

-0.02

-0.01

-0.03

17316

16750

105141 0 20627 38859

-16390

18992

1000

166350

153524

52197

6953

-275607

-224772

2166

-2166

3962

20000

94000

20000

340000

0 25000

330000

140000

30000

195000

5000

100000

240000

94000

88000

110000

6000

25000

0 115000

80100

58033

66000

75000

14100

73153

363900

225929

88293

-1009

115531

27238

8641

7632

58960 0 6700 0 112690 0 4135 0 731391 0 56355 0 240000 0

Nature of Business – Dthera Sciences (formerly Knowledge Machine International, Inc.) is a Nevada corporation, and was incorporated on December 12, 2013.   The Company offers a subscription-based service that captures, shares, and stores photos and audio in cloud. It offers the EveryStory platform, which enables users to preserve and share memories, and will initially target a Quality of Life benefit in certain patient populations, principally patients suffering from Alzheimer’s disease and dementia. On September 21, 2016, the Company acquired a new operating subsidiary, EveryStory, Inc., a Delaware corporation (“EveryStory”). Following the acquisition (referred to herein as the “EveryStory Transaction”), the Company’s business is to develop a Digital Therapeutic technology designed to deliver Reminiscence Therapy to certain patient populations, principally patients suffering from Alzheimer’s disease and dementia with the goal of a Quality of Life benefit and reduction in anxiety in those populations. As of the date of this Report, EveryStory was our only subsidiary. In connection with the EveryStory transaction, the Company dissolved its other former subsidiary entity and terminated its prior business operations.   Acquisition of EveryStory; EveryStory Transaction   On September 21, 2016, the Company entered into an Amended and Restated Acquisition and Share Exchange Agreement (the “A&R Agreement”) with EveryStory, Inc., a Delaware corporation (“EveryStory”), and each of its shareholder (the “Shareholders”), and closed the acquisition (the “Acquisition”) of the ownership of EveryStory (the “Closing”).   The Company acquired all of the outstanding shares of EveryStory, and agreed to issue an aggregate of 77,377,712 shares of the Company’s common stock to the EveryStory holders, with the understanding that an additional 45,247,288 shares were to be reserved for issuance to holders of EveryStory derivative securities which are convertible or exercisable into shares of EveryStory common stock (collectively, the “Exchange Shares”). Additionally, prior to Closing, the parties agreed that certain shares of the Company’s common stock were to be returned to the Company for cancellation, resulting in the current Company’s shareholders owning an aggregate of 40,875,000 shares of the Company’s common stock immediately prior to the Closing.   Pursuant to the A&R Agreement, the 122,625,000 Exchange Shares issued or to be issued to the EveryStory constituted 75% of the total issued and outstanding shares of the Company’s common stock, and the legacy Company shareholders (who were the owners of the Company’s common stock immediately prior to the Closing) owned an aggregate of 40,875,000 shares, which constituted 25% of the total outstanding Company common stock.   The Company’s and EveryStory’s management agreed, and the A&R Agreement provides, that following the Closing, the Company will conduct a reverse stock split (discussed in more detail below), following which the outstanding shares of the Company’s Series A Preferred Stock will convert into a total of 8,000,000 post-reverse-split common stock. Following such conversion, the EveryStory owners will own or have the right to receive shares of the Company’s common stock equal to 60% of the then-outstanding Company common stock, and the Company legacy shareholders will own shares of the Company’s common stock equal to 40% of the then-outstanding Company common stock, consisting of 8,000,000 shares of Company common stock issued on conversion of the Company’s Series A Preferred Stock (20%) and 8,000,000 shares of the Company’s common stock owned by the other legacy Company shareholders (20%).   As a result of the Closing of the A&R Agreement, EveryStory became a wholly owned subsidiary of the Company. Additionally, the directors and officers of the Company immediately prior to the Closing appointed the EveryStory management to become officers and directors of the Company, and then resigned from their positions with the Company. In addition, the Company terminated its pre-Closing business operations and agreed to dissolve its other wholly owned subsidiary, Knowledge Machine, Inc.   Immediately prior to the Closing, there were 40,875,000 shares of the Company’s common stock. In connection with the Closing, the Company issued an aggregate of 77,377,712 shares to the EveryStory shareholders, and 45,247,288 shares were reserved for issuance to the holders of EveryStory options and convertible debt instruments, and the parties to the A&R Agreement understand and anticipate that all such holders would exercise and convert their securities into the reserved shares of the Company.   On November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. All share numbers provided in this Quarterly Report are given on a post-reverse-split basis.   Accounting Basis   The Company’s financial statements are prepared using the accrual basis of accounting in accordance with U.S. GAAP.   As disclosed in a Current Report on Form 8-K filed November 17, 2016, the Company recently changed to a December 31 fiscal year end.   Use of Estimates   The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates are made in relation to the allowance for doubtful accounts and the fair value of certain financial instruments.   Principles of Consolidation   The consolidated financial statements include the accounts of Dthera Sciences and its subsidiaries. All significant inter-Company accounts and transactions have been eliminated.   Fair Value of Financial Instruments   The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.   The following are the hierarchical levels of inputs to measure fair value:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 6%"> </td> <td style="text-align: justify">Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.</td></tr> <tr> <td> </td> <td> </td></tr> <tr> <td style="vertical-align: top"> </td> <td style="text-align: justify">Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</td></tr> <tr> <td> </td> <td> </td></tr> <tr> <td style="vertical-align: top"> </td> <td style="text-align: justify">Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</td></tr> </table>   The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.   The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 2.   Embedded Conversion Features   The Company evaluates embedded conversion features within convertible debt under Accounting Standards Codification (“ASC”) 815, "Derivatives and Hedging" to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 "Debt with Conversion and Other Options" for consideration of any beneficial conversion feature.   Derivative Financial Instruments   The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.   For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.    Debt Issue Costs and Debt Discount   The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.    Stock-Based Compensation   The Company accounts for share based payments in accordance with ASC 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective – Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For this purpose, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders.   Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.   ASC 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this transition method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.   Loss Per Share   Basic loss per Common Share is computed by dividing losses attributable to Common shareholders by the weighted-average number of shares of Common Stock outstanding during the period.   Diluted loss per Common Share is computed by dividing loss attributable to Common shareholders by the weighted-average number of Shares of Common Stock outstanding during the period increased to include the number of additional Shares of Common Stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding convertible Preferred Stock, stock options, warrants, and convertible debt. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s Common Stock can result in a greater dilutive effect from potentially dilutive securities.   For the nine months ended September 30, 2016 and 2015, all of the Company’s potentially dilutive securities (warrants, options, convertible preferred stock, and convertible debt) were excluded from the computation of diluted earnings per share as they were anti-dilutive. The total number of potentially dilutive Common Shares that were excluded were 240,886 and 0 at nine months ended September 30, 2016 and 2015, respectively.   Recent Accounting Pronouncements   Management has considered all other recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

Nature of Business – Dthera Sciences (formerly Knowledge Machine International, Inc.) is a Nevada corporation, and was incorporated on December 12, 2013.   The Company offers a subscription-based service that captures, shares, and stores photos and audio in cloud. It offers the EveryStory platform, which enables users to preserve and share memories, and will initially target a Quality of Life benefit in certain patient populations, principally patients suffering from Alzheimer’s disease and dementia. On September 21, 2016, the Company acquired a new operating subsidiary, EveryStory, Inc., a Delaware corporation (“EveryStory”). Following the acquisition (referred to herein as the “EveryStory Transaction”), the Company’s business is to develop a Digital Therapeutic technology designed to deliver Reminiscence Therapy to certain patient populations, principally patients suffering from Alzheimer’s disease and dementia with the goal of a Quality of Life benefit and reduction in anxiety in those populations. As of the date of this Report, EveryStory was our only subsidiary. In connection with the EveryStory transaction, the Company dissolved its other former subsidiary entity and terminated its prior business operations.   Acquisition of EveryStory; EveryStory Transaction   On September 21, 2016, the Company entered into an Amended and Restated Acquisition and Share Exchange Agreement (the “A&R Agreement”) with EveryStory, Inc., a Delaware corporation (“EveryStory”), and each of its shareholder (the “Shareholders”), and closed the acquisition (the “Acquisition”) of the ownership of EveryStory (the “Closing”).   The Company acquired all of the outstanding shares of EveryStory, and agreed to issue an aggregate of 77,377,712 shares of the Company’s common stock to the EveryStory holders, with the understanding that an additional 45,247,288 shares were to be reserved for issuance to holders of EveryStory derivative securities which are convertible or exercisable into shares of EveryStory common stock (collectively, the “Exchange Shares”). Additionally, prior to Closing, the parties agreed that certain shares of the Company’s common stock were to be returned to the Company for cancellation, resulting in the current Company’s shareholders owning an aggregate of 40,875,000 shares of the Company’s common stock immediately prior to the Closing.   Pursuant to the A&R Agreement, the 122,625,000 Exchange Shares issued or to be issued to the EveryStory constituted 75% of the total issued and outstanding shares of the Company’s common stock, and the legacy Company shareholders (who were the owners of the Company’s common stock immediately prior to the Closing) owned an aggregate of 40,875,000 shares, which constituted 25% of the total outstanding Company common stock.   The Company’s and EveryStory’s management agreed, and the A&R Agreement provides, that following the Closing, the Company will conduct a reverse stock split (discussed in more detail below), following which the outstanding shares of the Company’s Series A Preferred Stock will convert into a total of 8,000,000 post-reverse-split common stock. Following such conversion, the EveryStory owners will own or have the right to receive shares of the Company’s common stock equal to 60% of the then-outstanding Company common stock, and the Company legacy shareholders will own shares of the Company’s common stock equal to 40% of the then-outstanding Company common stock, consisting of 8,000,000 shares of Company common stock issued on conversion of the Company’s Series A Preferred Stock (20%) and 8,000,000 shares of the Company’s common stock owned by the other legacy Company shareholders (20%).   As a result of the Closing of the A&R Agreement, EveryStory became a wholly owned subsidiary of the Company. Additionally, the directors and officers of the Company immediately prior to the Closing appointed the EveryStory management to become officers and directors of the Company, and then resigned from their positions with the Company. In addition, the Company terminated its pre-Closing business operations and agreed to dissolve its other wholly owned subsidiary, Knowledge Machine, Inc.   Immediately prior to the Closing, there were 40,875,000 shares of the Company’s common stock. In connection with the Closing, the Company issued an aggregate of 77,377,712 shares to the EveryStory shareholders, and 45,247,288 shares were reserved for issuance to the holders of EveryStory options and convertible debt instruments, and the parties to the A&R Agreement understand and anticipate that all such holders would exercise and convert their securities into the reserved shares of the Company.   On November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. All share numbers provided in this Quarterly Report are given on a post-reverse-split basis.

Accounting Basis   The Company’s financial statements are prepared using the accrual basis of accounting in accordance with U.S. GAAP.   As disclosed in a Current Report on Form 8-K filed November 17, 2016, the Company recently changed to a December 31 fiscal year end.

Use of Estimates   The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates are made in relation to the allowance for doubtful accounts and the fair value of certain financial instruments.

Principles of Consolidation   The consolidated financial statements include the accounts of Dthera Sciences and its subsidiaries. All significant inter-Company accounts and transactions have been eliminated.

Fair Value of Financial Instruments   The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.   The following are the hierarchical levels of inputs to measure fair value:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 6%"> </td> <td style="text-align: justify">Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.</td></tr> <tr> <td> </td> <td> </td></tr> <tr> <td style="vertical-align: top"> </td> <td style="text-align: justify">Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</td></tr> <tr> <td> </td> <td> </td></tr> <tr> <td style="vertical-align: top"> </td> <td style="text-align: justify">Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</td></tr> </table>   The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.   The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 2.

Embedded Conversion Features   The Company evaluates embedded conversion features within convertible debt under Accounting Standards Codification (“ASC”) 815, "Derivatives and Hedging" to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 "Debt with Conversion and Other Options" for consideration of any beneficial conversion feature.

Derivative Financial Instruments   The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.   For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

Debt Issue Costs and Debt Discount   The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.

Stock-Based Compensation   The Company accounts for share based payments in accordance with ASC 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective – Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For this purpose, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders.   Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.   ASC 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this transition method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.

Loss Per Share   Basic loss per Common Share is computed by dividing losses attributable to Common shareholders by the weighted-average number of shares of Common Stock outstanding during the period.   Diluted loss per Common Share is computed by dividing loss attributable to Common shareholders by the weighted-average number of Shares of Common Stock outstanding during the period increased to include the number of additional Shares of Common Stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding convertible Preferred Stock, stock options, warrants, and convertible debt. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s Common Stock can result in a greater dilutive effect from potentially dilutive securities.   For the nine months ended September 30, 2016 and 2015, all of the Company’s potentially dilutive securities (warrants, options, convertible preferred stock, and convertible debt) were excluded from the computation of diluted earnings per share as they were anti-dilutive. The total number of potentially dilutive Common Shares that were excluded were 240,886 and 0 at nine months ended September 30, 2016 and 2015, respectively.

Recent Accounting Pronouncements   Management has considered all other recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

On June 5, 2016, EveryStory issued 88,000 pre-split/614,340 post-split new shares for the purchase agreement for an SIT Patent at $0.67 per share for a value of $58,960. The price per share for Common Stock issued was based on the relative fair market value of the Common Stock using the backsolve valuation method.   The Company evaluated this acquisition in accordance with ASC 805, Business Combinations (10-55-4) to discern whether the assets and operations of SIT met the definition of a business. The Company concluded there were not a sufficient number of key processes obtained to develop the inputs into outputs, nor could such processes be easily obtained by the Company. Accordingly, the Company accounted for this transaction as the acquisition of assets.   The transaction was accounted for in accordance with asset acquisition guidance found in ASC 805. The consideration transferred and assets acquired recognized is as follows:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1pt solid">Consideration paid:</td><td style="font-weight: bold; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1pt solid">$</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Common Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">58,960</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; border-bottom: Black 1pt solid">Consideration received:</td><td style="font-weight: bold; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td style="font-weight: bold; text-align: left; border-bottom: Black 1pt solid">$</td><td style="font-weight: bold; text-align: right; border-bottom: Black 1pt solid"> </td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,960</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt; border-bottom: Black 2.5pt double">Net value of assets purchased:</td><td style="padding-bottom: 2.5pt; border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">58,960</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1pt solid">Consideration paid:</td><td style="font-weight: bold; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1pt solid">$</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Common Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">58,960</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; border-bottom: Black 1pt solid">Consideration received:</td><td style="font-weight: bold; padding-bottom: 1pt; border-bottom: Black 1pt solid"> </td> <td style="font-weight: bold; text-align: left; border-bottom: Black 1pt solid">$</td><td style="font-weight: bold; text-align: right; border-bottom: Black 1pt solid"> </td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,960</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt; border-bottom: Black 2.5pt double">Net value of assets purchased:</td><td style="padding-bottom: 2.5pt; border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">58,960</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Notes Payable – Related Parties   Notes payable due to related parties consisted of the following as of September 30, 2016 and December 31, 2015:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; font-weight: bold; padding-bottom: 2.5pt">Balance December 31, 2015</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">61,064</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">94,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Expense additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,627</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(80,100</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Conversions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(95,591</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance September 30, 2016</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>   During the nine months ended September 30, 2016 and the year ended December 31, 2015, the company Founder and CEO advanced $88,000 and $110,000, and expense additions of $20,627 and $68,904, and was repaid $66,000 and $75,000, respectively. The notes bear an interest rate of 0% per annum.   During the nine months ended September 30, 2016 and the year ended December 31, 2015, the company Founder and CTO advanced $6,000 and $25,000, and expense additions of $0 and $595, and was repaid $14,100 and $73,153, respectively. The notes bear an interest rate of 0% per annum.   On September 21, 2016, the Company’s wholly owned subsidiary (EveryStory) issued 112,690 shares of the EveryStory Series A Preferred Stock to the CEO and CTO in exchange for and as full payment of amounts to them which included $6,096 of accrued expenses, $95,591 of related party loans, $10,000 of convertible notes payable and $1,003 of accrued interest on the convertible notes payable. The EveryStory Series A Preferred stock are redeemable at any time for cash on a dollar-per-dollar basis at a redemption price of $1.00 per share. If not redeemed for cash, the shares of EveryStory Series A Preferred can be convertible into an aggregate of 160,986 shares of common stock, using a conversion price of $0.70 per share pursuant to the A&R Agreement.   Notes Payable   Notes payable consisted of the following as of September 30, 2016, and December 31, 2015:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; font-weight: bold">Balance December 31, 2015</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Expense additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Conversions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance September 30, 2016</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">20,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>   On August 3, 2016, the Company entered into a promissory note purchase agreement with an unrelated individual for $20,000, pursuant to the original version of the Share Exchange Agreement with EveryStory dated July 1, 2016. This note is due on demand. In lieu of interest, the Company issued 10,000 pre-split split shares of the Company’s common stock (69,811 post-split shares of the Company’s common stock) for a value of $6,700.   Convertible Notes Payable – Related Parties   Convertible notes payable due to related parties consisted of the following as of September 30, 2016, and December 31, 2015:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; font-weight: bold">Balance December 31, 2015</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 13%; font-weight: bold; text-align: right">60,000</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash additions</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">–</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Expense additions</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">–</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Conversions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(60,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Debt discount from debt issuance costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance September 30, 2016</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>   On June 29, 2015, the Company issued to two related party individuals convertible notes for $30,000 that mature on December 31, 2016. The notes bear an interest rate of 12% per annum and are convertible into shares of the Company’s common stock at the lesser of 70% of the price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $2,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing.   On November 18, 2015, the Company issued to two related party individuals convertible notes for $30,000 that mature on November 18, 2017. The notes bear an interest rate of 12% per annum and are convertible into shares of the Company’s common stock at the lesser of 60% of the lowest price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $5,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing.   On September 21, 2016, in connection with the EveryStory Transaction and the A&R Agreement, the Company's CEO converted the full balance of notes totaling $10,000 of principal and $1,003 of interest, and a director of the Company converted $50,000 of principal and $6,231 of interest into an aggregate of 478,419 shares of the Company’s common stock.    Convertible Notes Payable    Notes payable due to non-related parties consisted of the following as of September 30, 2016, and December 31, 2015:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; font-weight: bold">Balance December 31, 2015</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">465,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">New additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">340,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Conversions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(565,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(228,822</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance September 30, 2016</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,178</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>   On June 29, 2015, the Company issued to ten unrelated individuals convertible notes in the aggregate amount of $195,000 that mature on December 31, 2016. The notes bear an interest rate of 12% per annum and are convertible into shares of the Company’s common stock at the lesser of 70% of the price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $2,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing. On September 21, 2016, all of these convertible notes were converted into common stock based on the terms of the A&R Agreement.   On October 20, 2015, the Company issued to an unrelated individual a convertible note for $5,000 that matures on October 20, 2017. The note bears an interest rate of 12% per annum and is convertible into shares of the Company’s common stock at the lesser of 60% of the lowest price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $5,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing. On September 21, 2016, this convertible note was converted into common stock based on the terms of the A&R Agreement.   On November 18, 2015, the Company issued to eleven unrelated individuals convertible notes in the aggregate amount of $265,000 that mature on November 18, 2017. The notes bear an interest rate of 12% per annum and are convertible into shares of the Company’s common stock at the lesser of 60% of the lowest price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $5,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing. On September 21, 2016, all of these convertible notes were converted into common stock based on the terms of the A&R Agreement.   On February 9, 2016, the Company issued to an unrelated individual two convertible notes for $100,000 that mature on February 9, 2018. The notes bear an interest rate of 0% per annum and are convertible into shares of the Company’s common stock at the $1.60 per share. On September 21, 2016, these convertible notes were converted into common stock based on the terms of the A&R Agreement.   On September 13, 2016, the Company conducted a private offering of convertible notes (the “Note Offering”) to raise additional capital that would remain in the Company following the Closing of the EveryStory Transaction. In the convertible note offering, the Company raised an aggregate of $240,000, which will be a component of the post-Closing capitalization of the Company. In the Note Offering, investors entered into a securities purchase agreement (the “Note SPA”) and were issued a convertible redeemable promissory note (collectively, the “Convertible Notes”). Pursuant to the terms of the Note SPA, each investor represented and warranted that it was an accredited investor and that he or she was purchasing the Convertible Notes for his or her own account, and not with a view to distribution, as well as other standard representations made in private transactions. Also pursuant to the Note SPA, the Company has the right to put an additional Convertible Note (in the same principal amount as purchased by the applicable investor) beginning on January 3, 2017, subject to certain conditions. The Convertible Notes bear interest at a rate of 10%, and mature on September 13, 2017, if not converted or prepaid prior to that. The Convertible Notes convert into shares of the Company's common stock at a price for each share of Common Stock equal to 65% of the lowest closing bid price of the Common Stock as reported on the OTC Market platform on which the Company’s shares are quoted or any exchange upon which the Common Stock may be traded in the future ("Exchange"), on the date of the closing of the EveryStory Transaction. Up to 50% of the Convertible Notes may be repaid by the Company any time prior to 180 days after the issuance of the Convertible Notes, with a 30% premium to be paid in connection with the prepayment.   On September 21, 2016 as part of the EveryStory Transaction, 28 note holders converted promissory notes in the aggregate amount of $565,000 and interest totaling $56,256 into 566,503 pre-split/3,954,836 post-split shares of the Company’s common stock.   For the nine months ended September 30, 2016, conversions of convertible notes into common stock totaled $625,000 and interest totaling $63,713, converted into 635,033 pre-split/4,433,255 post-split shares of the Company’s common stock.

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; font-weight: bold; padding-bottom: 2.5pt">Balance December 31, 2015</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="width: 13%; border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">61,064</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">94,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Expense additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,627</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(80,100</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Conversions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(95,591</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance September 30, 2016</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>    Notes Payable   Notes payable consisted of the following as of September 30, 2016, and December 31, 2015:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; font-weight: bold">Balance December 31, 2015</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Expense additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Conversions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance September 30, 2016</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">20,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>    Convertible Notes Payable – Related Parties   Convertible notes payable due to related parties consisted of the following as of September 30, 2016, and December 31, 2015:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; font-weight: bold">Balance December 31, 2015</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 13%; font-weight: bold; text-align: right">60,000</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash additions</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">–</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Expense additions</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">–</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Conversions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(60,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Debt discount from debt issuance costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance September 30, 2016</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>     Convertible Notes Payable    Notes payable due to non-related parties consisted of the following as of September 30, 2016, and December 31, 2015:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; font-weight: bold">Balance December 31, 2015</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">465,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">340,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Conversions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(565,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(228,822</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance September 30, 2016</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,178</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balance at December 31, 2015</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issuances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">260,197</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Change in Fair Value of Derivative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(68,248</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at September 30, 2016</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">191,949</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<div style="font: 10pt Times New Roman, Times, Serif"> In accordance with ASC 855, Company’s management reviewed all material events through the date of this filing and determined that there were the following material subsequent events to report:   Reverse Stock Split; Conversion of Outstanding Knowledge Machine Series A Preferred Stock   On November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. In lieu of issuing fractional shares, the Company’s transfer agent was instructed to round up to the nearest whole share.   Immediately following the effectiveness of the Reverse Split, the Company’s 100,000 outstanding shares of Series A Preferred Stock were converted, pursuant to their terms, into 8,000,000 shares of post-Reverse Split common stock. Additionally, through the application of the Reverse Split, the 40,875,000 shares of common stock held by the legacy shareholders of Knowledge Machine following the closing of the EveryStory Transaction and immediately prior to the Reverse Split became 8,000,000 shares of common stock. Accordingly, the legacy shareholders of Knowledge Machine International, including the holders of the shares of Series A Preferred Stock, owned an aggregate of 16,000,000 shares of the Company’s common stock. The shares of the Company’s common stock held by the former EveryStory Shareholders went from 77,377,712 to 15,144,262 shares by virtue of the Reverse Split, with an additional 8,855,738 shares of the Company’s common stock reserved for issuance to the holders of EveryStory convertible instruments, including convertible notes, options, and other derivative securities.   Following the Reverse Split, the Company had 35,853,007 shares of common stock outstanding, consisting of 27,853,007 shares outstanding resulting from the Reverse Split, and the 8,000,000 shares of the Company’s common stock issued on conversion of the prior KMI Series A Preferred Stock immediately following the Reverse Split.   The Reverse Split was approved by the Board of Directors and the shareholders of the Company prior to the closing of the EveryStory Transaction, which approval was included in the closing conditions to the EveryStory Transaction.   Name Change; Ticker Symbol Change Requested   In connection with the closing of the EveryStory Transaction and the divestiture of the prior business and operations of the Company, as well as the new focus of the Company on the digital therapeutics and reminiscence therapy focus of the Company, the Board of Directors and the majority shareholders of the Company immediately following the closing of the EveryStory Transaction approved an amendment to the Company’s Articles of Incorporation to change the name of the Company (the “Name Change”) from Knowledge Machine International, Inc., to Dthera Sciences. The Name Change took effect at the same time as the Reverse Split on November 2, 2016.   In connection with the Name Change, and to help current shareholders and new investors better understand the business of the Company, the Company requested that a new ticker symbol be assigned to the Company. The Company has requested “DTHR” as the new ticker symbol, which will take effect twenty business days following the effectiveness of the Reverse Split (per FINRA rules).   New Website   Additionally, the Company launched a new website, www.dthera.com, to provide information about the Company, its business and operations, and additional information about digital therapeutics and reminiscence therapy. The link provided is for informational purposes only, and no information contained on the Company’s website should be deemed to be part of this or any filing of the Company.   Commencement of Clinical Trial   During November 2016, the University of California at San Diego began the previously disclosed clinical trial of the use of the EveryStory Platform as a Digital Therapeutic and Reminiscence Therapy treatment for patients with Alzheimer’s disease and other diagnoses of dementia. The Company anticipates that the clinical trial will be completed during the first quarter of 2017, and the Company will announce the results of the trial upon its completion.  </div>

-240620

240886

1880

1168

2816

58960

7100

61064

20000

60000

11178

465000

20627

68904

595

80100

95591

60000

565000

6096

95591

10000

1003

10000

50000

195000

5000

100000

565000

625000

730174

6700

228822

112690

566503

635033

635055

4433255

10000

69811

10000 6700

2016-12-31

2017-11-18

2016-12-31

2017-10-20

2018-02-09

2015-06-29

2015-11-18

2015-06-29

2015-10-20

2016-02-09

2016-09-13

.12

0.00

1003 6231 56256 63713

260197

-68248

0.95-.1 years

0.56-0.63% 106.33 -176.59%

0.00

The Company (Dthera) has authorized 200,000,000 shares of $0.001 par value per share Common Stock, of which 5,729,722 pre-split/40,000,000 post-split shares and 2,050,000 pre-split/14,311,341 post-split shares were issued outstanding as of September 30, 2016, and December 31, 2015, respectively.   On February 23, 2016, EveryStory amended its Certificate of Incorporation to increase the number of authorized shares to 100,000,000. The activity surrounding the issuances of the Common Stock by EveryStory is as follows:   Nine months Ended September 30, 2016   EveryStory issued 436,321 shares of EveryStory’s common stock for the services value of $41,875 and recorded a $34,875 gain on extinguishment of debt. EveryStory issued 614,340 shares of EveryStory’s common stock for the purchase agreement for an SIT Patent for a value of $58,960. The price per share for Common Stock issued for services was based on the relative fair market value of the Common Stock using the backsolve valuation method.   On September 21, 2016 as part of the A&R Agreement, EveryStory issued 635,055 pre-split/4,433,255 post-split shares of EveryStory’s common stock for the conversion of debt for a value of $730,174, and issued 10,000 pre-split/69,811 post split shares of EveryStory’s common stock in lieu of interest for a value of $6,700. EveryStory also issued 592,300 pre-split/4,134,930 post-split shares of EveryStory’s common stock for the conversion of 592,300 options. The Company exchanged 16,000,000 post-split shares of the Company’s common stock as part of the agreement totaling $56,355.   Year Ended December 31, 2015   EveryStory issued 900,000 pre-split/6,283,028 post-split shares of EveryStory Common Stock for net cash proceeds of $10,000 to Company founders. EveryStory also issued 50,000 pre-split/349,057 post-split shares of Common Stock as payment for services at $0.67 per share for a value of $33,500. The price per share for Common Stock issued for services was based on the relative fair market value of the Common Stock using the backsolve valuation method.

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Weighted Average Exercise Price $</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 1%; text-align: left"> </td><td style="width: 64%; text-align: left">Outstanding, December 31, 2015</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 13%; font-weight: bold; text-align: right">486,200</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">0.67</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: left">Granted</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">106,100</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">0.67</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"> </td><td style="text-align: left">Converted</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(592,300</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">–</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="text-align: left; padding-bottom: 2.5pt">Outstanding, September 30, 2016</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"> </td><td style="text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="text-align: left; padding-bottom: 2.5pt">Exercisable, September 30, 2016</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

436321

500000

349057

41875

33500

614340

58960

592300 592300 4134930 16000000 56355

900000

6283028

10000

486200

106100

486200

592300

0.00

0.67

0.00

680000

63678 75457 127200 359000

20000

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td colspan="2" style="text-align: center">September 30,</td> <td nowrap="nowrap" style="vertical-align: bottom"> </td></tr> <tr> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2016</td> <td nowrap="nowrap" style="vertical-align: bottom"> </td></tr> <tr style="background-color: rgb(238,238,238)"> <td>Expected term in years</td> <td style="vertical-align: bottom"> </td> <td colspan="2" style="text-align: right">1.00 - 0.95 years</td> <td nowrap="nowrap" style="vertical-align: bottom"> </td></tr> <tr style="background-color: White"> <td style="width: 81%">Risk-free interest rates</td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; width: 15%; text-align: right">0.56 - 0.63%</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 2%"> </td></tr> <tr style="background-color: rgb(238,238,238)"> <td>Volatility</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">103.83 - 176.59%</td> <td nowrap="nowrap" style="vertical-align: bottom"> </td></tr> <tr style="background-color: White"> <td>Dividend yield</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right">0%</td> <td nowrap="nowrap" style="vertical-align: bottom"> </td></tr> </table>

Liabilities measured at fair value on a recurring basis at September 30, 2016, are summarized as follows:    <div style="font: 10pt Times New Roman, Times, Serif"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"> </td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; width: 1%"> </td><td style="text-align: left; width: 30%">Fair value of options</td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">–</td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">–</td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">–</td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">–</td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: left">Fair value of derivatives</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">191,949</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">191,949</td><td style="text-align: left"> </td></tr> </table>   Liabilities measured at fair value on a recurring basis at December 31, 2015, are summarized as follows:    <div style="font: 10pt Times New Roman, Times, Serif"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold; text-align: right"> </td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; width: 1%"> </td><td style="text-align: left; width: 30%">Fair value of options</td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">–</td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">75,457</td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">–</td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">75,457</td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: left">Fair value of derivatives</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> </table>    </div>   Fair value is calculated using the Black-Scholes options pricing model.</div>

191949

0 0 0 75457 0 0 75457 0

Preferred Shares – EveryStory Inc.   The Company’s subsidiary, EveryStory, Inc. (“EveryStory”), has authorized 10,000,000 shares of $0.0001 par value per share Preferred Stock, of which 112,690 and 0 units were issued and outstanding as of September 30, 2016, and December 31, 2015, respectively.   On September 21, 2016, EveryStory issued 112,690 shares of the EveryStory Series A Preferred Stock to the CEO and CTO in exchange for and as full payment of amounts to them which included $6,096 of accrued expenses, $95,591 of related party loans, $10,000 of convertible notes payable and $1,003 of accrued interest on the convertible notes payable. The EveryStory Series A Preferred stock are redeemable at any time for cash on a dollar-per-dollar basis at a redemption price of $1.00 per share. If not redeemed for cash, the shares of EveryStory Series A Preferred can be converted into an aggregate of 160,986 shares of common stock (using a conversion price of $0.70 per share pursuant to the A&R Agreement.   Preferred Shares – Dthera Sciences   The Company has authorized 10,000,000 shares of $0.001 par value per share Preferred Stock, of which no shares were issued and outstanding as of the date of this Report.   Series A Convertible Preferred Stock   The Company authorized to issue 1,000,000 preferred shares, par value $0.001 per share, including 150,000 of which were designated as Series A Shares. The Series A Shares have the following rights and preferences:   <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">The Series A Shares are convertible into shares of the Company’s Common Stock at any time at a conversion rate of 80 shares of Common Stock for each Series A Share converted, subject to adjustments in the event of stock splits, recapitalizations, or similar events, provided that the Series A Shares will not be adjusted for any reverse stock split for a period of one year from the filing date of the Certificate of Designations creating the series, which is intended to occur with the first sale of Series A Shares in this offering.</td></tr></table>   <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">The Series A Shares are entitled to the number of votes equal to the number of whole shares of Common Stock into which the Series A Shares are convertible and vote together with the holders of the Common Stock, except as otherwise required by Nevada law or as provided in the Certificate of Designations for the Series A Shares.</td></tr></table>   <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">A majority vote of the outstanding Series A Shares voting as a single class is required for any of the following actions:</td></tr> <tr style="vertical-align: top"> <td> </td><td> </td><td style="text-align: justify"> </td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 96px"> </td> <td style="width: 48px">o</td> <td style="text-align: justify">Any alteration, amendment, or change in the rights, preferences or privileges of the Series A Shares;</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 96px"> </td> <td style="width: 48px">o</td> <td style="text-align: justify">Any amendment to the Company’s Certificate of Incorporation or Bylaws that would impair or reduce the rights of the Series A Shares; and</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 96px"> </td> <td style="width: 48px">o</td> <td style="text-align: justify">Any transaction resulting in the redemption of any of the Company’s securities.</td></tr> </table>   <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">·</td><td style="text-align: justify">In the event of any voluntary or involuntary liquidation, dissolution or winding up of our Company (including a disposition of substantially all of our assets, whether by sale, merger or other reorganization, or a sale of over 50% of the ownership of the Company), the holders of the Series A Shares will be entitled to receive the greater of 150% of the purchase price of the Series A Shares, plus accrued dividends, if any, or the amount distributed to the holders of the Common Stock as though the Series A Shares were converted. Liquidating distributions will be in preference to the holders of Common Stock.</td> </tr></table>   <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 60pt"></td><td style="width: 0.25in; text-align: left">·</td><td style="text-align: justify">The holders of the Series A Shares are not entitled to preference over the common shares on dividends, if any, declared by the Board.</td> </tr></table>   <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 60pt"></td><td style="width: 0.25in; text-align: left">·</td><td style="text-align: justify">There are no redemption or sinking fund provisions applicable to the Series A Shares.</td> </tr></table>   Pursuant to the terms of the A&R Agreement, following the effectiveness of the Reverse Split, all of the outstanding shares of the Company’s Series A Preferred Stock were converted into an aggregate of 160,986 shares of common stock of EveryStory (using a conversion price of $0.70 per share pursuant to the A&R Agreement), which then would be automatically converted into shares of the Company’s common stock, per the A&R Agreement.”

EX-101.SCH 6 sddl-20160930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - 1. Condensed Financial Statements link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 2. Going Concern link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 3. Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 4. Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 5. Asset Acquisition link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 6. Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 7. Loans Payable link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 8. Derivative Liabilities link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 9. Preferred Stock link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 10. Common Stock link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 11. Stock Purchase Options link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 12. Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 13. Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 3. Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 4. Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 5. Asset Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 6. Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 7. Loans Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 8. Derivative Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 11. Stock Purchase Options (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 12. Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 2. Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 3. Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 4. Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 5. Asset Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 6. Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 7. Loans Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - 7. Loans Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - 8. Derivative Liabilities (Details - Level 2) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - 8. Derivative Liabilities (Details - Assumptions) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - 10. Common Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - 11. Stock Purchase Options (Details - Option activity) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - 11. Stock Purchase Options (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - 12. Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 sddl-20160930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 sddl-20160930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 sddl-20160930_lab.xml XBRL LABEL FILE Notes Payable - Related Parties [Member] Long-term Debt, Type [Axis] Notes Payable [Member] Convertible Notes Payable - Related Parties [Member] Convertible Notes Payable [Member] Founder and CEO [Member] Related Party [Axis] EveryStory Series A Preferred Stock [Member] Class of Stock [Axis] Accrued Expenses [Member] Debt Conversion Description [Axis] Related Party Loans [Member] Accrued Interest [Member] Unrelated Individual [Member] Counterparty Name [Axis] Two Individuals [Member] Two Individuals [Member] Founder and CTO [Member] Chief Executive Officer [Member] Common Stock [Member] Ten Individuals [Member] Unrelated Individual [Member] Note Offering [Member] Securities Financing Transaction [Axis] 28 Note Holders Total [Member] EveryStory Transaction [Member] Transaction Type [Axis] Total Conversions [Member] Convertible Notes [Member] Derivative Instrument [Axis] Pre-Split Shares [Member] Report Date [Axis] Post-Split Shares [Member] EveryStory Legal Entity [Axis] Shareholders' Equity Class [Axis] Interest Converted [Member] Dthera Sciences [Member] Options [Member] Award Type [Axis] Fair Value, Measurements, Recurring [Member] Measurement Frequency [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash Prepaid expenses Deposits TOTAL CURRENT ASSETS LONG TERM ASSETS Property and equipment, net TOTAL LONG TERM ASSETS TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and accrued liabilities Accrued interest Derivative liabilities Notes payable-related party Notes payable Convertible notes payable, net Convertible notes payable-related party, net TOTAL CURRENT LIABILITIES LONG TERM LIABILITIES Notes payable Convertible notes payable-related party, net TOTAL LONG TERM LIABILITIES TOTAL LIABILITIES STOCKHOLDERS' DEFICIT Preferred stock 1,000,000 Shares Authorized; $0.001 Par Value; 112,690 and 0 shares issued and outstanding as at September 30, 2016 and December 31, 2015 Common stock 200,000,000 Shares Authorized; $0.001 Par Value; 40,000,000 and 14,353,091 shares issued and outstanding as of September 30, 2016 and December 31, 2015 Additional paid in capital Accumulated deficit Total Stockholders' Deficit Total Liabilities and Stockholders' Deficit Preferred stock, par value Preferred stock, authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock Par value Common stock, Authorized Common stock, Issued Common stock, outstanding Income Statement [Abstract] REVENUES Sales Cost of services GROSS PROFIT OPERATING EXPENSES Amortization and depreciation General and administrative Professional fees TOTAL OPERATING EXPENSES OPERATING LOSS OTHER EXPENSES Interest expense Derivative expense Gain on derivative liability Gain on extinguishment of debt Impairment of intangible assets TOTAL OTHER EXPENSES NET LOSS WEIGHTED AVERAGE SHARES OUTSTANDING - Basic and diluted Loss per share - Basic and diluted Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net Income (Loss) Adjustments for non-cash items: Amortization and depreciation Impairment of intangible assets Stock issued for services Gain on extinguishment of debt Gain on derivative liability Initial derivative expense Options issued for services Operating expense paid in behalf of the company Changes in operating assets and liabilities: Prepaid expenses Deposits Accounts payable and accrued liabilities Accrued interest NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES Property and equipment NET CASH USED IN INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from issuance of common stock, net Proceeds from issuance of notes payable Proceeds from issuance of notes payable - related party Proceeds from issuance of convertible notes Proceeds from issuance of notes payable - related party Proceeds from issuance of convertible notes - related party Payments of notes payable - related party NET CASH PROVIDED BY FINANCING ACTIVITIES NET CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS - Beginning of period CASH AND CASH EQUIVALENTS - End of period NON-CASH INVESTING AND FINANCING ACTIVITIES Shares issued for assets Common stock issued for interest Preferred shares issued for debt Share issued in settlement of stock options Shares issued in settlement of debt Assets & liabilities settled in Share exchange Debt discount on convertible debt Organization, Consolidation and Presentation of Financial Statements [Abstract] 1. Condensed Financial Statements 2. Going Concern Accounting Policies [Abstract] 3. Summary of Significant Accounting Policies Property, Plant and Equipment [Abstract] 4. Property and Equipment Business Combinations [Abstract] 5. Asset Acquisition Goodwill and Intangible Assets Disclosure [Abstract] 6. Intangible Assets Debt Disclosure [Abstract] 7. Loans Payable Derivative Instruments and Hedging Activities Disclosure [Abstract] 8. Derivative Liabilities Equity [Abstract] 9. Preferred Stock 10. Common Stock Disclosure of Compensation Related Costs, Share-based Payments [Abstract] 11. Stock Purchase Options Fair Value Disclosures [Abstract] 12. Fair Value Measurements Subsequent Events [Abstract] 13. Subsequent Events Nature of Business Accounting Basis Use of Estimates Principles of Consolidation Fair Value of Financial Instruments Embedded Conversion Features EX-101.PRE 10 sddl-20160930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2016	Nov. 21, 2016
Document And Entity Information
Entity Registrant Name	Dthera Sciences
Entity Central Index Key	0001586372
Document Type	10-QT
Document Period End Date	Sep. 30, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		40,000,000
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2016

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
CURRENT ASSETS
Cash	$ 115,531	$ 27,238
Prepaid expenses	5,000	21,390
Deposits	1,000	1,000
TOTAL CURRENT ASSETS	121,531	49,628
LONG TERM ASSETS
Property and equipment, net	936	1,648
TOTAL LONG TERM ASSETS	936	1,648
TOTAL ASSETS	122,467	51,276
CURRENT LIABILITIES
Accounts payable and accrued liabilities	139,960	149,965
Accrued interest	0	17,993
Derivative liabilities	191,949	0
Notes payable-related party	0	61,064
Notes payable	20,000	0
Convertible notes payable, net	11,178	189,243
Convertible notes payable-related party, net	0	29,114
TOTAL CURRENT LIABILITIES	363,087	447,379
LONG TERM LIABILITIES
Notes payable	0	270,000
Convertible notes payable-related party, net	0	30,000
TOTAL LONG TERM LIABILITIES	0	300,000
TOTAL LIABILITIES	363,087	747,379
STOCKHOLDERS' DEFICIT
Preferred stock 1,000,000 Shares Authorized; $0.001 Par Value; 112,690 and 0 shares issued and outstanding as at September 30, 2016 and December 31, 2015	11	0
Common stock 200,000,000 Shares Authorized; $0.001 Par Value; 40,000,000 and 14,353,091 shares issued and outstanding as of September 30, 2016 and December 31, 2015	40,000	14,311
Additional paid in capital	1,159,377	73,182
Accumulated deficit	(1,440,008)	(783,596)
Total Stockholders' Deficit	(240,620)	(696,103)
Total Liabilities and Stockholders' Deficit	$ 122,467	$ 51,276

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, shares issued	112,690	0
Preferred stock, shares outstanding	112,690	0
Common stock Par value	$ 0.001	$ 0.001
Common stock, Authorized	200,000,000	100,000,000
Common stock, Issued	40,000,000	14,353,091
Common stock, outstanding	40,000,000	14,353,091

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
REVENUES
Sales	$ 0	$ 0	$ 0	$ 0
Cost of services	0	0	0	0
GROSS PROFIT	0	0	0	0
OPERATING EXPENSES
Amortization and depreciation	239	0	712	0
General and administrative	136,209	177,010	388,402	259,229
Professional fees	183,312	37,317	212,464	137,934
TOTAL OPERATING EXPENSES	319,760	214,327	601,578	397,163
OPERATING LOSS	(319,760)	(214,327)	(601,578)	(397,163)
OTHER EXPENSES
Interest expense	(32,962)	(6,805)	(68,800)	(6,953)
Derivative expense	(30,197)	0	(30,197)	0
Gain on derivative liability	68,248	0	68,248	0
Gain on extinguishment of debt	34,875	0	34,875	0
Impairment of intangible assets	0	0	(58,960)	0
TOTAL OTHER EXPENSES	39,964	(6,805)	(54,834)	(6,953)
NET LOSS	$ (279,796)	$ (221,132)	$ (656,412)	$ (404,116)
WEIGHTED AVERAGE SHARES OUTSTANDING - Basic and diluted	17,713,943	14,774,889	15,512,115	11,852,384
Loss per share - Basic and diluted	$ (0.02)	$ (0.01)	$ (0.04)	$ (0.03)

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (Loss)	$ (279,796)	$ (221,132)	$ (656,412)	$ (404,116)
Adjustments for non-cash items:
Amortization and depreciation			17,316	0
Impairment of intangible assets	0	0	58,960	0	$ 7,100
Stock issued for services			16,750	0
Gain on extinguishment of debt	(34,875)	0	(34,875)	0
Gain on derivative liability	(68,248)	0	(68,248)	0
Initial derivative expense	30,197	0	30,197	0
Options issued for services			105,141	0
Operating expense paid in behalf of the company			20,627	38,859
Changes in operating assets and liabilities:
Prepaid expenses			16,390	(18,992)
Deposits			0	(1,000)
Accounts payable and accrued liabilities			166,350	153,524
Accrued interest			52,197	6,953
NET CASH USED IN OPERATING ACTIVITIES			(275,607)	(224,772)
CASH FLOWS FROM INVESTING ACTIVITIES
Property and equipment			0	(2,166)
NET CASH USED IN INVESTING ACTIVITIES			0	(2,166)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock, net			0	3,962
Proceeds from issuance of notes payable			20,000	0
Proceeds from issuance of notes payable - related party			0	25,000
Proceeds from issuance of convertible notes			330,000	140,000
Proceeds from issuance of notes payable - related party			94,000	0
Proceeds from issuance of convertible notes - related party			0	115,000
Payments of notes payable - related party			(80,100)	(58,033)
NET CASH PROVIDED BY FINANCING ACTIVITIES			363,900	225,929
NET CHANGE IN CASH AND CASH EQUIVALENTS			88,293	(1,009)
CASH AND CASH EQUIVALENTS - Beginning of period			27,238	8,641	8,641
CASH AND CASH EQUIVALENTS - End of period	$ 115,531	$ 7,632	115,531	7,632	$ 27,238
NON-CASH INVESTING AND FINANCING ACTIVITIES
Shares issued for assets			58,960	0
Common stock issued for interest			6,700	0
Preferred shares issued for debt			112,690	0
Share issued in settlement of stock options			4,135	0
Shares issued in settlement of debt			731,391	0
Assets & liabilities settled in Share exchange			56,355	0
Debt discount on convertible debt			$ 240,000	$ 0

XML 16 R6.htm IDEA: XBRL DOCUMENT

1. Condensed Financial Statements

9 Months Ended

Sep. 30, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

1. Condensed Financial Statements

XML 17 R7.htm IDEA: XBRL DOCUMENT

2. Going Concern

9 Months Ended

Sep. 30, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

2. Going Concern

XML 18 R8.htm IDEA: XBRL DOCUMENT

3. Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2016

Accounting Policies [Abstract]

3. Summary of Significant Accounting Policies

Nature of Business – Dthera Sciences (formerly Knowledge Machine International, Inc.) is a Nevada corporation, and was incorporated on December 12, 2013.

Acquisition of EveryStory; EveryStory Transaction

Accounting Basis

Use of Estimates

Principles of Consolidation

The consolidated financial statements include the accounts of Dthera Sciences and its subsidiaries. All significant inter-Company accounts and transactions have been eliminated.

Fair Value of Financial Instruments

The following are the hierarchical levels of inputs to measure fair value:

	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

	Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 2.

Embedded Conversion Features

Derivative Financial Instruments

Debt Issue Costs and Debt Discount

Stock-Based Compensation

Loss Per Share

Basic loss per Common Share is computed by dividing losses attributable to Common shareholders by the weighted-average number of shares of Common Stock outstanding during the period.

Recent Accounting Pronouncements

XML 19 R9.htm IDEA: XBRL DOCUMENT

4. Property and Equipment

9 Months Ended

Sep. 30, 2016

Property, Plant and Equipment [Abstract]

4. Property and Equipment

The Company’s property and equipment were comprised of the following as of September 30, 2016, and December 31, 2015:

	September 30, 2016			December 31, 2015
Computer & Equipment		2,816			2,816
Less: Accumulated Depreciation		(1,880	)		(1,168	)
Net Property and Equipment	$	936		$	1,648

XML 20 R10.htm IDEA: XBRL DOCUMENT

5. Asset Acquisition

9 Months Ended

Sep. 30, 2016

Business Combinations [Abstract]

5. Asset Acquisition

The transaction was accounted for in accordance with asset acquisition guidance found in ASC 805. The consideration transferred and assets acquired recognized is as follows:

Consideration paid:	$
Common Stock		58,960

Consideration received:	$
Intangible assets		58,960

Net value of assets purchased:		58,960

XML 21 R11.htm IDEA: XBRL DOCUMENT

6. Intangible Assets

9 Months Ended

Sep. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

6. Intangible Assets

The Company’s intangible assets were comprised of the following of September 30, 2016, and December 31, 2015:

	September 30, 2016			December 31, 2015
Technology asset purchase	$	58,960		$	7,100
Less: Accumulated Amortization		–			–
Less: Impairment		(58,960	)		(7,100	)
Net Intangible Assets	$	–		$	–

XML 22 R12.htm IDEA: XBRL DOCUMENT

7. Loans Payable

9 Months Ended

Sep. 30, 2016

Debt Disclosure [Abstract]

7. Loans Payable

Notes Payable – Related Parties

Notes payable due to related parties consisted of the following as of September 30, 2016 and December 31, 2015:

Balance December 31, 2015	$	61,064
Cash additions		94,000
Expense additions		20,627
Cash payments		(80,100	)
Conversions		(95,591	)
Balance September 30, 2016	$	–

Notes Payable

Notes payable consisted of the following as of September 30, 2016, and December 31, 2015:

Balance December 31, 2015	$	–
Cash additions		20,000
Expense additions		–
Cash payments		–
Conversions		–
Balance September 30, 2016	$	20,000

Convertible Notes Payable – Related Parties

Convertible notes payable due to related parties consisted of the following as of September 30, 2016, and December 31, 2015:

Balance December 31, 2015	$	60,000
Cash additions		–
Expense additions		–
Conversions		(60,000	)
Debt discount from debt issuance costs		–
Balance September 30, 2016	$	–

Convertible Notes Payable

Notes payable due to non-related parties consisted of the following as of September 30, 2016, and December 31, 2015:

Balance December 31, 2015	$	465,000
New additions		340,000
Conversions		(565,000	)
Debt discount		(228,822	)
Balance September 30, 2016	$	11,178

XML 23 R13.htm IDEA: XBRL DOCUMENT

8. Derivative Liabilities

9 Months Ended

Sep. 30, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

8. Derivative Liabilities

Balance at December 31, 2015	$	–
Issuances		260,197
Change in Fair Value of Derivative		(68,248	)
Balance at September 30, 2016	$	191,949

	September 30,
	2016
Expected term in years	1.00 - 0.95 years
Risk-free interest rates		0.56 - 0.63%
Volatility		103.83 - 176.59%
Dividend yield		0%

XML 24 R14.htm IDEA: XBRL DOCUMENT

9. Preferred Stock

9 Months Ended

Sep. 30, 2016

Equity [Abstract]

9. Preferred Stock

Preferred Shares – EveryStory Inc.

On September 21, 2016, EveryStory issued 112,690 shares of the EveryStory Series A Preferred Stock to the CEO and CTO in exchange for and as full payment of amounts to them which included $6,096 of accrued expenses, $95,591 of related party loans, $10,000 of convertible notes payable and $1,003 of accrued interest on the convertible notes payable. The EveryStory Series A Preferred stock are redeemable at any time for cash on a dollar-per-dollar basis at a redemption price of $1.00 per share. If not redeemed for cash, the shares of EveryStory Series A Preferred can be converted into an aggregate of 160,986 shares of common stock (using a conversion price of $0.70 per share pursuant to the A&R Agreement.

Preferred Shares – Dthera Sciences

The Company has authorized 10,000,000 shares of $0.001 par value per share Preferred Stock, of which no shares were issued and outstanding as of the date of this Report.

Series A Convertible Preferred Stock

	·	A majority vote of the outstanding Series A Shares voting as a single class is required for any of the following actions:

	o	Any alteration, amendment, or change in the rights, preferences or privileges of the Series A Shares;

	o	Any amendment to the Company’s Certificate of Incorporation or Bylaws that would impair or reduce the rights of the Series A Shares; and

Any transaction resulting in the redemption of any of the Company’s securities.

The holders of the Series A Shares are not entitled to preference over the common shares on dividends, if any, declared by the Board.

There are no redemption or sinking fund provisions applicable to the Series A Shares.

XML 25 R15.htm IDEA: XBRL DOCUMENT

10. Common Stock

9 Months Ended

Sep. 30, 2016

Equity [Abstract]

10. Common Stock

Nine months Ended September 30, 2016

Year Ended December 31, 2015

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 26 R16.htm IDEA: XBRL DOCUMENT

11. Stock Purchase Options

9 Months Ended

Sep. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

11. Stock Purchase Options

Stock Purchase Options

The following table summarizes the changes in options outstanding of the Company during the nine months ending September 30, 2016:

	Number of Options			Weighted Average Exercise Price $
Outstanding, December 31, 2015		486,200			0.67
Granted		106,100			0.67
Converted		(592,300	)		–
Outstanding, September 30, 2016		–			–

Exercisable, September 30, 2016		–			–

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 27 R17.htm IDEA: XBRL DOCUMENT

12. Fair Value Measurements

9 Months Ended

Sep. 30, 2016

Fair Value Disclosures [Abstract]

12. Fair Value Measurements

Liabilities measured at fair value on a recurring basis at September 30, 2016, are summarized as follows:

	Level 1		Level 2		Level 3		Total
Fair value of options	$	–	$	–	$	–	$	–
Fair value of derivatives	$	–	$	191,949	$	–	$	191,949

Liabilities measured at fair value on a recurring basis at December 31, 2015, are summarized as follows:

	Level 1		Level 2		Level 3		Total
Fair value of options	$	–	$	75,457	$	–	$	75,457
Fair value of derivatives	$	–	$	–	$	–	$	–

Fair value is calculated using the Black-Scholes options pricing model.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 28 R18.htm IDEA: XBRL DOCUMENT

13. Subsequent Events	9 Months Ended
13. Subsequent Events	Sep. 30, 2016
Subsequent Events [Abstract]
13. Subsequent Events	In accordance with ASC 855, Company’s management reviewed all material events through the date of this filing and determined that there were the following material subsequent events to report: Reverse Stock Split; Conversion of Outstanding Knowledge Machine Series A Preferred Stock On November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. In lieu of issuing fractional shares, the Company’s transfer agent was instructed to round up to the nearest whole share. Immediately following the effectiveness of the Reverse Split, the Company’s 100,000 outstanding shares of Series A Preferred Stock were converted, pursuant to their terms, into 8,000,000 shares of post-Reverse Split common stock. Additionally, through the application of the Reverse Split, the 40,875,000 shares of common stock held by the legacy shareholders of Knowledge Machine following the closing of the EveryStory Transaction and immediately prior to the Reverse Split became 8,000,000 shares of common stock. Accordingly, the legacy shareholders of Knowledge Machine International, including the holders of the shares of Series A Preferred Stock, owned an aggregate of 16,000,000 shares of the Company’s common stock. The shares of the Company’s common stock held by the former EveryStory Shareholders went from 77,377,712 to 15,144,262 shares by virtue of the Reverse Split, with an additional 8,855,738 shares of the Company’s common stock reserved for issuance to the holders of EveryStory convertible instruments, including convertible notes, options, and other derivative securities. Following the Reverse Split, the Company had 35,853,007 shares of common stock outstanding, consisting of 27,853,007 shares outstanding resulting from the Reverse Split, and the 8,000,000 shares of the Company’s common stock issued on conversion of the prior KMI Series A Preferred Stock immediately following the Reverse Split. The Reverse Split was approved by the Board of Directors and the shareholders of the Company prior to the closing of the EveryStory Transaction, which approval was included in the closing conditions to the EveryStory Transaction. Name Change; Ticker Symbol Change Requested In connection with the closing of the EveryStory Transaction and the divestiture of the prior business and operations of the Company, as well as the new focus of the Company on the digital therapeutics and reminiscence therapy focus of the Company, the Board of Directors and the majority shareholders of the Company immediately following the closing of the EveryStory Transaction approved an amendment to the Company’s Articles of Incorporation to change the name of the Company (the “Name Change”) from Knowledge Machine International, Inc., to Dthera Sciences. The Name Change took effect at the same time as the Reverse Split on November 2, 2016. In connection with the Name Change, and to help current shareholders and new investors better understand the business of the Company, the Company requested that a new ticker symbol be assigned to the Company. The Company has requested “DTHR” as the new ticker symbol, which will take effect twenty business days following the effectiveness of the Reverse Split (per FINRA rules). New Website Additionally, the Company launched a new website, www.dthera.com, to provide information about the Company, its business and operations, and additional information about digital therapeutics and reminiscence therapy. The link provided is for informational purposes only, and no information contained on the Company’s website should be deemed to be part of this or any filing of the Company. Commencement of Clinical Trial During November 2016, the University of California at San Diego began the previously disclosed clinical trial of the use of the EveryStory Platform as a Digital Therapeutic and Reminiscence Therapy treatment for patients with Alzheimer’s disease and other diagnoses of dementia. The Company anticipates that the clinical trial will be completed during the first quarter of 2017, and the Company will announce the results of the trial upon its completion.

XML 29 R19.htm IDEA: XBRL DOCUMENT

3. Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2016

Accounting Policies [Abstract]

Nature of Business

Nature of Business – Dthera Sciences (formerly Knowledge Machine International, Inc.) is a Nevada corporation, and was incorporated on December 12, 2013.

Acquisition of EveryStory; EveryStory Transaction

Accounting Basis

Use of Estimates

Principles of Consolidation

The consolidated financial statements include the accounts of Dthera Sciences and its subsidiaries. All significant inter-Company accounts and transactions have been eliminated.

Fair Value of Financial Instruments

The following are the hierarchical levels of inputs to measure fair value:

	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

	Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 2.

Embedded Conversion Features

Derivative Financial Instruments

Debt Issue Costs and Debt Discount

Stock-Based Compensation

Loss Per Share

Basic loss per Common Share is computed by dividing losses attributable to Common shareholders by the weighted-average number of shares of Common Stock outstanding during the period.

Recent Accounting Pronouncements

XML 30 R20.htm IDEA: XBRL DOCUMENT

4. Property and Equipment (Tables)

9 Months Ended

Sep. 30, 2016

Property, Plant and Equipment [Abstract]

Property and equipment schedule

	September 30, 2016			December 31, 2015
Computer & Equipment		2,816			2,816
Less: Accumulated Depreciation		(1,880	)		(1,168	)
Net Property and Equipment	$	936		$	1,648

XML 31 R21.htm IDEA: XBRL DOCUMENT

5. Asset Acquisition (Tables)

9 Months Ended

Sep. 30, 2016

Business Combinations [Abstract]

Consideration transferred

Consideration paid:	$
Common Stock		58,960

Consideration received:	$
Intangible assets		58,960

Net value of assets purchased:		58,960

XML 32 R22.htm IDEA: XBRL DOCUMENT

6. Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible assets

	September 30, 2016			December 31, 2015
Technology asset purchase	$	58,960		$	7,100
Less: Accumulated Amortization		–			–
Less: Impairment		(58,960	)		(7,100	)
Net Intangible Assets	$	–		$	–

XML 33 R23.htm IDEA: XBRL DOCUMENT

7. Loans Payable (Tables)

9 Months Ended

Sep. 30, 2016

Debt Disclosure [Abstract]

Notes payable - related parties

Balance December 31, 2015	$	61,064
Cash additions		94,000
Expense additions		20,627
Cash payments		(80,100	)
Conversions		(95,591	)
Balance September 30, 2016	$	–

Notes Payable

Notes payable consisted of the following as of September 30, 2016, and December 31, 2015:

Balance December 31, 2015	$	–
Cash additions		20,000
Expense additions		–
Cash payments		–
Conversions		–
Balance September 30, 2016	$	20,000

Convertible Notes Payable – Related Parties

Convertible notes payable due to related parties consisted of the following as of September 30, 2016, and December 31, 2015:

Balance December 31, 2015	$	60,000
Cash additions		–
Expense additions		–
Conversions		(60,000	)
Debt discount from debt issuance costs		–
Balance September 30, 2016	$	–

Convertible Notes Payable

Notes payable due to non-related parties consisted of the following as of September 30, 2016, and December 31, 2015:

Balance December 31, 2015	$	465,000
Cash additions		340,000
Conversions		(565,000	)
Debt discount		(228,822	)
Balance September 30, 2016	$	11,178

XML 34 R24.htm IDEA: XBRL DOCUMENT

8. Derivative Liabilities (Tables)

9 Months Ended

Sep. 30, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative liability - Level 2

Balance at December 31, 2015	$	–
Issuances		260,197
Change in Fair Value of Derivative		(68,248	)
Balance at September 30, 2016	$	191,949

Assumptions

	September 30,
	2016
Expected term in years	1.00 - 0.95 years
Risk-free interest rates		0.56 - 0.63%
Volatility		103.83 - 176.59%
Dividend yield		0%

XML 35 R25.htm IDEA: XBRL DOCUMENT

11. Stock Purchase Options (Tables)

9 Months Ended

Sep. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Option activity

	Number of Options			Weighted Average Exercise Price $
Outstanding, December 31, 2015		486,200			0.67
Granted		106,100			0.67
Converted		(592,300	)		–
Outstanding, September 30, 2016		–			–

Exercisable, September 30, 2016		–			–

XML 36 R26.htm IDEA: XBRL DOCUMENT

12. Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2016

Fair Value Disclosures [Abstract]

Fair Value Measurements

Liabilities measured at fair value on a recurring basis at September 30, 2016, are summarized as follows:

	Level 1		Level 2		Level 3		Total
Fair value of options	$	–	$	–	$	–	$	–
Fair value of derivatives	$	–	$	191,949	$	–	$	191,949

Liabilities measured at fair value on a recurring basis at December 31, 2015, are summarized as follows:

	Level 1		Level 2		Level 3		Total
Fair value of options	$	–	$	75,457	$	–	$	75,457
Fair value of derivatives	$	–	$	–	$	–	$	–

Fair value is calculated using the Black-Scholes options pricing model.

XML 37 R27.htm IDEA: XBRL DOCUMENT

2. Going Concern (Details Narrative) - USD ($)	9 Months Ended
2. Going Concern (Details Narrative) - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ (1,440,008)		$ (783,596)
Working capital	$ (240,620)
Antidilutive securities excluded from EPS	240,886	0

XML 38 R28.htm IDEA: XBRL DOCUMENT

3. Summary of Significant Accounting Policies (Details Narrative) - shares	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Accounting Policies [Abstract]
Antidilutive shares excluded from EPS	240,886	0

XML 39 R29.htm IDEA: XBRL DOCUMENT

4. Property and Equipment (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Computer and equipment	$ 2,816	$ 2,816
Less: Accumulated depreciation	(1,880)	(1,168)
Net property and equipment	$ 936	$ 1,648

XML 40 R30.htm IDEA: XBRL DOCUMENT

5. Asset Acquisition (Details)	9 Months Ended
5. Asset Acquisition (Details)	Sep. 30, 2016 USD ($)
Business Combinations [Abstract]
Consideration paid, stock value	$ 58,960
Consideration received, intangible assets	58,960
Net value of assets purchased	$ 58,960

XML 41 R31.htm IDEA: XBRL DOCUMENT

6. Intangible Assets (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
6. Intangible Assets (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Technology asset purchase	$ 58,960		$ 58,960		$ 7,100
Less: Accumulated Amortization	0		0		0
Less: Impairment	0	$ 0	(58,960)	$ 0	(7,100)
Net Intangible Assets	$ 0		$ 0		$ 0

XML 42 R32.htm IDEA: XBRL DOCUMENT

7. Loans Payable (Details) - USD ($)	9 Months Ended
7. Loans Payable (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015
Cash additions	$ 20,000	$ 0
Notes Payable - Related Parties [Member]
Balance, beginning	61,064
Cash additions	94,000
Cash payments	(80,100)
Conversions	(95,591)
Balance, ending	0
Notes Payable [Member]
Balance, beginning	0
Cash additions	20,000
Expense additions	0
Cash payments	0
Conversions	0
Balance, ending	20,000
Convertible Notes Payable - Related Parties [Member]
Balance, beginning	60,000
Cash additions	0
Expense additions	0
Cash payments	0
Conversions	(60,000)
Debt discount from debt issuance costs	0
Balance, ending	0
Convertible Notes Payable [Member]
Balance, beginning	465,000
Cash additions	340,000
Conversions	(565,000)
Debt discount from debt issuance costs	(228,822)
Balance, ending	$ 11,178

XML 43 R33.htm IDEA: XBRL DOCUMENT

7. Loans Payable (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
7. Loans Payable (Details Narrative) - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Proceeds from related party	$ 94,000	$ 0
Cash payments	80,100	58,033
Proceeds from convertible debt	330,000	$ 140,000
Chief Executive Officer [Member] \| EveryStory Series A Preferred Stock [Member]
Debt converted, amount	10,000
Interest converted, amount	1,003
Chief Executive Officer [Member] \| Common Stock [Member]
Debt converted, amount	50,000
Interest converted, amount	6,231
Notes Payable - Related Parties [Member]
Debt converted, amount	95,591
Notes Payable - Related Parties [Member] \| Founder and CEO [Member]
Proceeds from related party	88,000		$ 110,000
Expense additions	20,627		68,904
Cash payments	66,000		75,000
Notes Payable - Related Parties [Member] \| Founder and CEO [Member] \| Accrued Expenses [Member]
Debt converted, amount	6,096
Notes Payable - Related Parties [Member] \| Founder and CEO [Member] \| Related Party Loans [Member]
Debt converted, amount	95,591
Notes Payable - Related Parties [Member] \| Founder and CEO [Member] \| Convertible Notes Payable [Member]
Debt converted, amount	10,000
Notes Payable - Related Parties [Member] \| Founder and CEO [Member] \| Accrued Interest [Member]
Debt converted, amount	$ 1,003
Notes Payable - Related Parties [Member] \| Founder and CEO [Member] \| EveryStory Series A Preferred Stock [Member]
Stock issued for conversion of debt, shares issued	112,690
Notes Payable - Related Parties [Member] \| Founder and CTO [Member]
Proceeds from related party	$ 6,000		25,000
Expense additions	0		595
Cash payments	14,100		$ 73,153
Notes Payable [Member]
Expense additions	0
Debt converted, amount	$ 0
Notes Payable [Member] \| Unrelated Individual [Member]
Stock issued in lieu of interest, shares	10,000
Stock issued in lieu of interest, value	$ 6,700
Convertible Notes Payable - Related Parties [Member]
Expense additions	0
Debt converted, amount	$ 60,000
Convertible Notes Payable - Related Parties [Member] \| Two Individuals [Member]
Debt issuance date	Jun. 29, 2015
Proceeds from convertible debt	$ 30,000
Debt maturity date	Dec. 31, 2016
Debt stated interest rate	12.00%
Convertible Notes Payable - Related Parties [Member] \| Two Individuals [Member]
Debt issuance date	Nov. 18, 2015
Proceeds from convertible debt	$ 30,000
Debt maturity date	Nov. 18, 2017
Debt stated interest rate	12.00%
Convertible Notes Payable [Member]
Debt converted, amount	$ 565,000
Convertible Notes Payable [Member] \| Note Offering [Member]
Debt issuance date	Sep. 13, 2016
Proceeds from convertible debt	$ 240,000
Convertible Notes Payable [Member] \| Unrelated Individual [Member]
Debt converted, amount	$ 5,000
Debt issuance date	Oct. 20, 2015
Proceeds from convertible debt	$ 5,000
Debt maturity date	Oct. 20, 2017
Debt stated interest rate	12.00%
Convertible Notes Payable [Member] \| Ten Individuals [Member]
Debt converted, amount	$ 195,000
Debt issuance date	Jun. 29, 2015
Proceeds from convertible debt	$ 195,000
Debt maturity date	Dec. 31, 2016
Debt stated interest rate	12.00%
Convertible Notes Payable [Member] \| Unrelated Individual [Member]
Debt converted, amount	$ 100,000
Debt issuance date	Feb. 09, 2016
Proceeds from convertible debt	$ 100,000
Debt maturity date	Feb. 09, 2018
Debt stated interest rate	0.00%
Convertible Notes Payable [Member] \| 28 Note Holders Total [Member] \| EveryStory Transaction [Member]
Stock issued for conversion of debt, shares issued	566,503
Debt converted, amount	$ 565,000
Interest converted, amount	$ 56,256
Convertible Notes Payable [Member] \| Total Conversions [Member]
Stock issued for conversion of debt, shares issued	635,033
Debt converted, amount	$ 625,000
Interest converted, amount	$ 63,713

XML 44 R34.htm IDEA: XBRL DOCUMENT

8. Derivative Liabilities (Details - Level 2) - Convertible Notes [Member]	9 Months Ended
	Sep. 30, 2016 USD ($)
Derivative liability, beginning balance	$ 0
Issuances	260,197
Change in Fair Value of Derivative	$ (68,248)

XML 45 R35.htm IDEA: XBRL DOCUMENT

8. Derivative Liabilities (Details - Assumptions)	9 Months Ended
8. Derivative Liabilities (Details - Assumptions)	Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Expected term in years	0.95-.1 years
Risk-free interest rates	0.56-0.63%
Volatility	106.33 -176.59%
Dividend yield	0.00%

XML 46 R36.htm IDEA: XBRL DOCUMENT

10. Common Stock (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
10. Common Stock (Details Narrative) - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Common stock outstanding	40,000,000		40,000,000		14,353,091
Gain on extinguishment of debt	$ 34,875	$ 0	$ 34,875	$ 0
EveryStory \| Common Stock [Member]
Stock issued for services, shares			436,321
Stock issued for services, value			$ 41,875
Gain on extinguishment of debt			$ 34,875
Stock issued for patent, shares			614,340
Stock issued for patent, value			$ 58,960
Dthera Sciences [Member] \| Common Stock [Member]
Stock exchanged, shares			16,000,000
Conversion value			$ 56,355
Pre-Split Shares [Member]
Common stock outstanding	5,729,722		5,729,722		40,000,000
Pre-Split Shares [Member] \| EveryStory
Stock issued for services, shares			500,000
Stock issued for services, value			$ 33,500
Conversion of debt, stock issued			635,055
Conversion of debt, amount converted			$ 730,174
Options converted, options converted			592,300
Options converted, shares issued			592,300
Stock issued new, shares			900,000
Stock issued new, value			$ 10,000
Pre-Split Shares [Member] \| EveryStory \| Interest Converted [Member]
Conversion of debt, stock issued			10,000
Conversion of debt, amount converted			$ 6,700
Post-Split Shares [Member]
Common stock outstanding	2,050,000		2,050,000		14,311,341
Post-Split Shares [Member] \| EveryStory
Stock issued for services, shares			349,057
Conversion of debt, stock issued			4,433,255
Options converted, shares issued			4,134,930
Stock issued new, shares			6,283,028
Post-Split Shares [Member] \| EveryStory \| Interest Converted [Member]
Conversion of debt, stock issued			69,811

XML 47 R37.htm IDEA: XBRL DOCUMENT

11. Stock Purchase Options (Details - Option activity) - Options [Member]	9 Months Ended
	Sep. 30, 2016 $ / shares shares
Number of Options
Options outstanding, beginning balance	486,200
Options granted	106,100
Options converted	(592,300)
Options outstanding, ending balance	0
Options exercisable	0
Weighted Average Exercise Price
Weighted average exercise price, options outstanding, beginning balance \| $ / shares	$ 0.67
Weighted average exercise price, options granted \| $ / shares	0.67
Weighted average exercise price, options outstanding, ending balance \| $ / shares	0.00
Weighted average exercise price, options exercisable \| $ / shares	$ 0.00

XML 48 R38.htm IDEA: XBRL DOCUMENT

11. Stock Purchase Options (Details Narrative) - Options [Member] - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Options granted	106,100
EveryStory
Shares reserved for issuance	680,000
Options granted	106,100	486,200
Options granted, value	$ 63,678	$ 75,457
Options issued for services, options issued		127,200
Options issued for employment agreements, options issued		359,000

XML 49 R39.htm IDEA: XBRL DOCUMENT

12. Fair Value Measurements (Details) - Fair Value, Measurements, Recurring [Member] - USD ($)	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015
Fair value of options		$ 75,457	$ 0
Fair value of derivatives		0	$ 191,949
Fair Value, Inputs, Level 1 [Member]
Fair value of options	$ 0	0
Fair value of derivatives	0	0
Fair Value, Inputs, Level 2 [Member]
Fair value of options	0	75,457
Fair value of derivatives	191,949	0
Fair Value, Inputs, Level 3 [Member]
Fair value of options	0	0
Fair value of derivatives	$ 0	$ 0

EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ਐ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end XML 51 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 52 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 73 175 1 false 34 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://dtherasciences.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://dtherasciences.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://dtherasciences.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://dtherasciences.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://dtherasciences.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - 1. Condensed Financial Statements Sheet http://dtherasciences.com/role/CondensedFinancialStatements 1. Condensed Financial Statements Notes 6 false false R7.htm 00000007 - Disclosure - 2. Going Concern Sheet http://dtherasciences.com/role/GoingConcern 2. Going Concern Notes 7 false false R8.htm 00000008 - Disclosure - 3. Summary of Significant Accounting Policies Sheet http://dtherasciences.com/role/SummaryOfSignificantAccountingPolicies 3. Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - 4. Property and Equipment Sheet http://dtherasciences.com/role/PropertyAndEquipment 4. Property and Equipment Notes 9 false false R10.htm 00000010 - Disclosure - 5. Asset Acquisition Sheet http://dtherasciences.com/role/AssetAcquisition 5. Asset Acquisition Notes 10 false false R11.htm 00000011 - Disclosure - 6. Intangible Assets Sheet http://dtherasciences.com/role/IntangibleAssets 6. Intangible Assets Notes 11 false false R12.htm 00000012 - Disclosure - 7. Loans Payable Sheet http://dtherasciences.com/role/LoansPayable 7. Loans Payable Notes 12 false false R13.htm 00000013 - Disclosure - 8. Derivative Liabilities Sheet http://dtherasciences.com/role/DerivativeLiabilities 8. Derivative Liabilities Notes 13 false false R14.htm 00000014 - Disclosure - 9. Preferred Stock Sheet http://dtherasciences.com/role/PreferredStock 9. Preferred Stock Notes 14 false false R15.htm 00000015 - Disclosure - 10. Common Stock Sheet http://dtherasciences.com/role/CommonStock 10. Common Stock Notes 15 false false R16.htm 00000016 - Disclosure - 11. Stock Purchase Options Sheet http://dtherasciences.com/role/StockPurchaseOptions 11. Stock Purchase Options Notes 16 false false R17.htm 00000017 - Disclosure - 12. Fair Value Measurements Sheet http://dtherasciences.com/role/FairValueMeasurements 12. Fair Value Measurements Notes 17 false false R18.htm 00000018 - Disclosure - 13. Subsequent Events Sheet http://dtherasciences.com/role/SubsequentEvents 13. Subsequent Events Notes 18 false false R19.htm 00000019 - Disclosure - 3. Summary of Significant Accounting Policies (Policies) Sheet http://dtherasciences.com/role/SummaryOfSignificantAccountingPoliciesPolicies 3. Summary of Significant Accounting Policies (Policies) Policies http://dtherasciences.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - 4. Property and Equipment (Tables) Sheet http://dtherasciences.com/role/PropertyAndEquipmentTables 4. Property and Equipment (Tables) Tables http://dtherasciences.com/role/PropertyAndEquipment 20 false false R21.htm 00000021 - Disclosure - 5. Asset Acquisition (Tables) Sheet http://dtherasciences.com/role/AssetAcquisitionTables 5. Asset Acquisition (Tables) Tables http://dtherasciences.com/role/AssetAcquisition 21 false false R22.htm 00000022 - Disclosure - 6. Intangible Assets (Tables) Sheet http://dtherasciences.com/role/IntangibleAssetsTables 6. Intangible Assets (Tables) Tables http://dtherasciences.com/role/IntangibleAssets 22 false false R23.htm 00000023 - Disclosure - 7. Loans Payable (Tables) Sheet http://dtherasciences.com/role/LoansPayableTables 7. Loans Payable (Tables) Tables http://dtherasciences.com/role/LoansPayable 23 false false R24.htm 00000024 - Disclosure - 8. Derivative Liabilities (Tables) Sheet http://dtherasciences.com/role/DerivativeLiabilitiesTables 8. Derivative Liabilities (Tables) Tables http://dtherasciences.com/role/DerivativeLiabilities 24 false false R25.htm 00000025 - Disclosure - 11. Stock Purchase Options (Tables) Sheet http://dtherasciences.com/role/StockPurchaseOptionsTables 11. Stock Purchase Options (Tables) Tables http://dtherasciences.com/role/StockPurchaseOptions 25 false false R26.htm 00000026 - Disclosure - 12. Fair Value Measurements (Tables) Sheet http://dtherasciences.com/role/FairValueMeasurementsTables 12. Fair Value Measurements (Tables) Tables http://dtherasciences.com/role/FairValueMeasurements 26 false false R27.htm 00000027 - Disclosure - 2. Going Concern (Details Narrative) Sheet http://dtherasciences.com/role/GoingConcernDetailsNarrative 2. Going Concern (Details Narrative) Details http://dtherasciences.com/role/GoingConcern 27 false false R28.htm 00000028 - Disclosure - 3. Summary of Significant Accounting Policies (Details Narrative) Sheet http://dtherasciences.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative 3. Summary of Significant Accounting Policies (Details Narrative) Details http://dtherasciences.com/role/SummaryOfSignificantAccountingPoliciesPolicies 28 false false R29.htm 00000029 - Disclosure - 4. Property and Equipment (Details) Sheet http://dtherasciences.com/role/PropertyAndEquipmentDetails 4. Property and Equipment (Details) Details http://dtherasciences.com/role/PropertyAndEquipmentTables 29 false false R30.htm 00000030 - Disclosure - 5. Asset Acquisition (Details) Sheet http://dtherasciences.com/role/AssetAcquisitionDetails 5. Asset Acquisition (Details) Details http://dtherasciences.com/role/AssetAcquisitionTables 30 false false R31.htm 00000031 - Disclosure - 6. Intangible Assets (Details) Sheet http://dtherasciences.com/role/IntangibleAssetsDetails 6. Intangible Assets (Details) Details http://dtherasciences.com/role/IntangibleAssetsTables 31 false false R32.htm 00000032 - Disclosure - 7. Loans Payable (Details) Sheet http://dtherasciences.com/role/LoansPayableDetails 7. Loans Payable (Details) Details http://dtherasciences.com/role/LoansPayableTables 32 false false R33.htm 00000033 - Disclosure - 7. Loans Payable (Details Narrative) Sheet http://dtherasciences.com/role/LoansPayableDetailsNarrative 7. Loans Payable (Details Narrative) Details http://dtherasciences.com/role/LoansPayableTables 33 false false R34.htm 00000034 - Disclosure - 8. Derivative Liabilities (Details - Level 2) Sheet http://dtherasciences.com/role/DerivativeLiabilitiesDetails-Level2 8. Derivative Liabilities (Details - Level 2) Details http://dtherasciences.com/role/DerivativeLiabilitiesTables 34 false false R35.htm 00000035 - Disclosure - 8. Derivative Liabilities (Details - Assumptions) Sheet http://dtherasciences.com/role/DerivativeLiabilitiesDetails-Assumptions 8. Derivative Liabilities (Details - Assumptions) Details http://dtherasciences.com/role/DerivativeLiabilitiesTables 35 false false R36.htm 00000036 - Disclosure - 10. Common Stock (Details Narrative) Sheet http://dtherasciences.com/role/CommonStockDetailsNarrative 10. Common Stock (Details Narrative) Details http://dtherasciences.com/role/CommonStock 36 false false R37.htm 00000037 - Disclosure - 11. Stock Purchase Options (Details - Option activity) Sheet http://dtherasciences.com/role/StockPurchaseOptionsDetails-OptionActivity 11. Stock Purchase Options (Details - Option activity) Details http://dtherasciences.com/role/StockPurchaseOptionsTables 37 false false R38.htm 00000038 - Disclosure - 11. Stock Purchase Options (Details Narrative) Sheet http://dtherasciences.com/role/StockPurchaseOptionsDetailsNarrative 11. Stock Purchase Options (Details Narrative) Details http://dtherasciences.com/role/StockPurchaseOptionsTables 38 false false R39.htm 00000039 - Disclosure - 12. Fair Value Measurements (Details) Sheet http://dtherasciences.com/role/FairValueMeasurementsDetails 12. Fair Value Measurements (Details) Details http://dtherasciences.com/role/FairValueMeasurementsTables 39 false false All Reports Book All Reports sddl-20160930.xml sddl-20160930.xsd sddl-20160930_cal.xml sddl-20160930_def.xml sddl-20160930_lab.xml sddl-20160930_pre.xml true true ZIP 56 0001683168-16-000762-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-16-000762-xbrl.zip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end